These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
27-1204330
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
1 Primerica Parkway
Duluth, Georgia
|
|
30099
|
|
(Address of principal executive offices)
|
|
(ZIP Code)
|
|
Title of each class
|
Name of each exchange on which registered
|
|
Common Stock, $.01 Par Value
|
New York Stock Exchange
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
our failure to continue to attract and license new recruits, retain sales representatives, or license or maintain the licensing of our sales representatives;
|
|
•
|
changes to the independent contractor status of our sales representatives;
|
|
•
|
our or our sales representatives’ violation of, or non-compliance, with laws and regulations;
|
|
•
|
our or our sales representatives' failure to protect the confidentiality of client information;
|
|
•
|
differences between our actual experience and our expectations regarding mortality, persistency, expenses and investment yields as reflected in the pricing for our insurance policies;
|
|
•
|
the occurrence of a catastrophic event that causes a large number of premature deaths of our insureds;
|
|
•
|
changes in federal and state legislation and regulation, including other legislation or regulation that affects our insurance and investment product businesses;
|
|
•
|
our failure to meet risk-based capital standards or other minimum capital or surplus requirements;
|
|
•
|
a downgrade or potential downgrade in our insurance subsidiaries’ financial strength ratings or in the investment grade credit ratings for our senior unsecured debt;
|
|
•
|
the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio;
|
|
•
|
incorrectly valuing our investments;
|
|
•
|
inadequate or unaffordable reinsurance or the failure of our reinsurers to perform their obligations;
|
|
•
|
the failure of, or legal challenges to, the support tools we provide to our sales force;
|
|
•
|
heightened standards of conduct or more stringent licensing requirements for our sales representatives;
|
|
•
|
inadequate policies and procedures regarding suitability review of client transactions;
|
|
•
|
the inability of our subsidiaries to pay dividends or make distributions;
|
|
•
|
our ability to generate and maintain a sufficient amount of working capital;
|
|
•
|
our non-compliance with the covenants of our senior unsecured debt;
|
|
•
|
legal and regulatory investigations and actions concerning us or our sales representatives;
|
|
•
|
the loss of key personnel;
|
|
•
|
the failure of our information technology systems, breach of our information security or failure of our business continuity plan; and
|
|
•
|
fluctuations in Canadian currency exchange rates.
|
|
•
|
Address our clients' financial needs.
Our sales representatives primarily use our proprietary financial needs analysis tool (“FNA”) and an educational approach to demonstrate how our products can assist clients to provide financial protection for their families, save for their retirement and other needs, and manage their debt. Typically, our clients are the friends, family members and personal acquaintances of our sales representatives. Meetings are generally held in informal, face-to-face settings, usually in the clients' homes.
|
|
•
|
Provide a business opportunity.
We provide an entrepreneurial business opportunity for individuals to distribute our financial products. Low entry costs and the ability to begin part-time allow our sales representatives to supplement their income by starting their own independent businesses without incurring significant start-up costs or leaving their current jobs. Our unique compensation structure, technology, training and back-office processing are designed to enable our sales representatives to successfully grow their independent businesses.
|
|
•
|
Primerica Financial Services, Inc. (“PFS”), our general agency and marketing company;
|
|
•
|
Primerica Life Insurance Company (“Primerica Life”), our principal life insurance underwriting company; and
|
|
•
|
PFS Investments Inc. (“PFS Investments”), our investment and savings products company, broker-dealer and registered investment advisor.
|
|
•
|
Primerica Life Insurance Company of Canada (“Primerica Life Canada”), our Canadian life insurance underwriting company;
|
|
•
|
PFSL Investments Canada Ltd. ("PFSL Investments Canada"), our Canadian licensed mutual fund dealer; and
|
|
•
|
PFSL Fund Management Ltd. ("PFSL Fund Management"), our Canadian investment funds manager.
|
|
•
|
They have inadequate or no life insurance coverage.
Individual life insurance sales in the United States declined from
12.5 million
policy sales in
1975
to
6.2 million
policy sales in
2012
, the latest period for which data is available, according to the Life Insurance Marketing and Research Association International, Inc. ("LIMRA"), a
|
|
•
|
They need help saving for retirement and other personal goals.
Middle income families continually find it challenging to save for retirement and other goals. By developing personalized savings programs for our clients using our proprietary FNA and offering a wide range of mutual funds, annuities, managed accounts and segregated fund products sponsored and managed by reputable firms, our sales representatives are well equipped to help clients develop long-term savings plans to address their financial needs.
|
|
•
|
They need to reduce their consumer debt.
Many middle income families have numerous debt obligations from credit cards, auto loans, and home mortgages. We help our clients address these financial burdens by providing personalized client-driven debt resolution techniques and third party referrals that can help them reduce and ultimately pay off their debts.
|
|
•
|
They prefer to meet face-to-face when considering financial products.
Historically, middle income consumers have indicated a preference to meet face-to-face when considering financial products or services. As such, we have designed our business model to address this preference in a cost-effective manner.
|
|
•
|
Independent entrepreneurs:
Our sales representatives are independent contractors building and operating their own businesses. This business-within-a-business approach means that our sales representatives are entrepreneurs who take responsibility for selling products, recruiting sales representatives, setting their own schedules and managing and paying the expenses associated with their sales activities, including office rent and administrative overhead, with minimal start-up costs.
|
|
•
|
Part-time opportunity:
By offering a flexible part-time opportunity, we are able to attract a significant number of recruits who desire to earn supplemental income and generally concentrate on smaller-sized transactions typical of middle income consumers. Our sales representatives distribute our products directly to consumers, and therefore our business opportunity does not require recruits to purchase and resell our products. Our sales representatives are able to join our sales force at minimal expense, and they receive technological support, pre-licensing training and licensing examination preparation programs. Virtually all of our sales representatives begin selling our products on a part-time basis, which enables them to hold jobs while exploring an opportunity with us.
|
|
•
|
Incentive to build distribution:
When a sale is made, the selling representative receives a commission, as does the representative who recruited and supervises him or her, which we refer to as override compensation. Override compensation is paid through several levels of the selling representative's recruitment and supervisory organization. This structure motivates existing sales representatives to grow our sales force and provides them with commission income from the sales completed by their recruits.
|
|
•
|
Sales force leadership
: A sales representative who has built a successful organization and has obtained his or her life insurance license can achieve the sales designation of Regional Vice President ("RVP"), which entitles him or her to earn higher compensation and bonuses. RVPs are independent contractors who open and operate offices for their sales organizations and devote their full attention to their Primerica businesses. RVPs also support and monitor the part-time sales representatives on whose sales they earn override commissions in compliance with applicable regulatory requirements. RVPs' efforts to expand their businesses are a primary driver of our success.
|
|
•
|
Innovative compensation system:
We have developed an innovative system for compensating our independent sales force that is contingent upon product sales. We advance to our sales representatives a significant portion of their insurance commissions upon their submission of an insurance application and the first month's premium payment. In addition to being a source of motivation, this upfront payment provides our sales representatives with immediate cash flow to offset costs associated with originating the business. In addition, monthly production bonuses are paid to RVPs whose downline sales organizations meet certain sales levels. With compensation tied to sales activity, our compensation approach accommodates varying degrees of individual productivity, which allows us to effectively use a large group of part-time sales representatives while providing a variable cost structure. In addition, we incentivize our RVPs with equity compensation on a quarterly basis, which aligns their interests with those of our stockholders.
|
|
•
|
Large, dynamic sales force:
Members of our sales force primarily serve their friends, family members and personal acquaintances through individually driven networking activities. We believe that this warm market approach is an effective way to distribute our products because it facilitates face-to-face interaction initiated by a
|
|
•
|
Motivational culture:
In addition to the motivation for our sales representatives to achieve financial success, we seek to create a culture that inspires and rewards our sales representatives for their personal successes and those of their sales organizations through sales force recognition events and contests. We also use in-house television broadcasts and local, regional and national meetings to inform and teach our sales representatives, as well as facilitate camaraderie and the exchange of ideas across the sales force organization. These initiatives encourage and empower our sales representatives to develop their own successful sales organizations as part of Primerica.
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
Number of new recruits
|
|
|
186,251
|
|
|
|
191,752
|
|
|
|
244,756
|
|
|
Number of newly insurance-licensed sales representatives
|
|
|
34,155
|
|
|
|
34,425
|
|
|
|
33,711
|
|
|
Number of insurance-licensed sales representatives, at period end
|
|
|
95,566
|
|
|
|
92,373
|
|
|
|
91,176
|
|
|
Average number of insurance-licensed sales representatives during period
|
|
|
93,086
|
|
|
|
90,981
|
|
|
|
91,855
|
|
|
•
|
compensating our sales representatives for product sales by them and their downline organizations;
|
|
•
|
helping our sales representatives learn financial fundamentals so they can confidently and effectively assist our clients;
|
|
•
|
reducing the administrative burden on our sales force, which allows them to devote more of their time to building a downline organization and selling products; and
|
|
•
|
creating a culture in which sales representatives are encouraged to achieve goals through the recognition of their sales and recruiting achievements, as well as those of their sales organizations.
|
|
•
|
Primerica Online ("POL"), which is our secure Internet website designed to be a support system for our sales force. POL provides sales representatives with access to their Primerica e-mail, bulletins and alerts, business tracking tools and real-time updates on their pending life applications and new recruits. We also use POL to provide real-time recognition of sales representatives' successes and scoreboards for sales force production, contests and trips. In addition, POL is a gateway to our product providers and product support. A substantial majority of our sales representatives subscribe to POL. Subscribers generally pay a
$25
monthly fee to subscribe to POL, which helps cover the cost of maintaining this support system.
|
|
•
|
our in-house TV network, which is broadcast by Internet-streaming video. We create original broadcasts and videos that enable senior management to update our sales force and provide training and motivational presentations. We broadcast a live weekly program hosted by home office management and selected RVPs that focuses on new developments and provides motivational messages to our sales force. We also broadcast a training-oriented program to our sales force on a weekly basis and profile successful sales representatives, allowing these individuals to educate and train our other sales representatives by sharing their secrets for success.
|
|
•
|
our publications department, which produces materials to support, motivate, and inform our sales force. We sell recruiting materials, sales pieces, business cards and stationery and provide total communications services, including web design, print presentations, graphic design and script writing. We also produce a weekly mailing that includes materials promoting our current incentives, as well as the latest news about our product offerings.
|
|
•
|
Our Financial Needs Analysis:
Our FNA is a proprietary, web-based, needs-based analysis tool. The FNA gives our sales representatives the ability to collect and synthesize client financial data and develop a financial analysis for the client that is easily understood. The FNA, while not a financial plan, provides our clients with a personalized explanation of how our products work and introduces prudent financial concepts, such as regular saving and accelerating the repayment of high cost credit card debt to help them reach their financial goals. The FNA provides clients with a snapshot of their current financial position and identifies their life insurance, savings and debt resolution needs.
|
|
•
|
Our Point-of-Sale Application Tool:
Our web-based, point-of-sale software, TurboApps, is an internally developed system that streamlines the application process for our insurance products. This application populates client information from the FNA to eliminate redundant data collection and provides real-time feedback to eliminate incomplete and illegible applications. Integrated with our paperless field office management system described below and with our home office systems, TurboApps allows our RVPs and us to realize the efficiencies of straight-through-processing of application data and other information collected on our sales representatives' mobile devices, which results in expedited processing of our life insurance product sales. We also leverage the TurboApps concept with our investment partners to process U.S. mutual fund and annuity product sales. We developed web-based versions of TurboApps to take advantage of the proliferation of portable devices and wireless Internet connections, including smartphones, laptop computers and tablets.
|
|
•
|
Virtual Base Shop:
In an effort to ease the administrative burden on RVPs and simplify sales force operations, we make available to RVPs a secure Internet-based paperless field office management system as part of the POL subscription. This virtual office is designed to automate the RVP's administrative responsibilities and can be accessed by all sales representatives in an RVP's immediate downline sales organization, which we refer to as his or her base shop.
|
|
•
|
Other Tools
: We utilize proprietary and third-party products, including web-based software and mobile devices and applications, for more efficient application processing, client support, and sales force administration, among other uses. For example, our Primerica App for Android and iOS are broadly used by our sales force for managing contacts, generating client proposals, and receiving and sending communications. In addition to our Primerica App, we continue to develop mobile applications for our web-based software as the use of mobile devices by our sales representatives increases.
|
|
•
|
a toll-free sales support call center to address questions and assist with paperwork, underwriting and licensing;
|
|
•
|
a tele-underwriting process that allows clients to provide needed medical information without disclosing it to our sales representatives; and
|
|
•
|
POL for tracking the status of pending life insurance applications and the progress of their new recruits in their training and licensing efforts.
|
|
•
|
sales commissions and fees based on their personal sales and client assets under management;
|
|
•
|
override commissions based on sales by sales representatives and fees based on client assets under management in their downline organizations;
|
|
•
|
bonuses and other compensation, including equity-based compensation, based on their own sales performance, the aggregate sales performance of their downline organizations and other criteria; and
|
|
•
|
participation in our contests and other incentive programs.
|
|
•
|
Consistent with sound individual finance principles:
Products must be consistent with good personal finance principles for middle income consumers, such as financial protection, minimizing expenses, encouraging long-term savings and reducing debt.
|
|
•
|
Designed to support multiple client goals:
Products are designed to address and support a broad range of financial goals rather than compete with or cannibalize each other. For example, term life insurance does not compete with mutual funds because term life has no cash value or investment element.
|
|
•
|
Ongoing needs based:
Products are designed to meet the ongoing financial needs of many middle income consumers. This long-term approach bolsters our relationship with our clients by allowing us to continue to serve them as their financial needs evolve.
|
|
•
|
Easily understood and sold:
Products must be appropriate for distribution by our sales force, which requires that the application and approval process must be simple to understand and explain, and the likelihood of approval must be sufficiently high to justify the investment of time by our sales representatives.
|
|
Operating Segment
|
|
Principal Products
|
|
Principal Sources of Products
(Applicable Geographic Territory)
|
|
Term Life Insurance
|
|
Term Life Insurance
|
|
Primerica Life (U.S. (except New York), the
|
|
|
|
|
|
District of Columbia and certain territories)
|
|
|
|
|
|
NBLIC (New York)
|
|
|
|
|
|
Primerica Life Canada (Canada)
|
|
|
|
|
||
|
Investment and Savings
|
|
Mutual Funds and
|
|
American Century Investments (U.S.)
|
|
Products
|
|
Certain Retirement Plans
|
|
American Funds (U.S.)
|
|
|
|
|
|
Franklin Templeton (U.S.)
|
|
|
|
|
|
ING Life Insurance and Annuity Company (U.S.)
|
|
|
|
|
|
Invesco (U.S.)
|
|
|
|
|
|
Legg Mason Global Asset Management (U.S.)
|
|
|
|
|
|
Pioneer Investments (U.S.)
|
|
|
|
|
|
AGF Funds (Canada)
|
|
|
|
|
|
Concert™ Funds (Canada)
|
|
|
|
|
|
Mackenzie Investments (Canada)
|
|
|
|
|
|
|
|
|
|
Managed Accounts
|
|
Lockwood Advisors (U.S.)
|
|
|
|
|
||
|
|
|
Variable Annuities
|
|
Lincoln National Life Insurance Company and
|
|
|
|
|
|
its affiliates (U.S.)
|
|
|
|
|
|
MetLife Investors and its affiliates (U.S.)
|
|
|
|
|
||
|
|
|
Fixed Indexed Annuities
|
|
Lincoln National Life Insurance Company and
|
|
|
|
|
|
its affiliates (U.S.)
|
|
|
|
|
|
|
|
|
|
Fixed Annuities
|
|
MetLife Investors USA Life Insurance Company and
|
|
|
|
|
|
its affiliates (U.S.)
|
|
|
|
|
||
|
|
|
Segregated Funds
|
|
Primerica Life Canada (Canada)
|
|
|
|
|
||
|
Corporate and Other
|
|
Credit Information Services
|
|
Equifax Consumer Services LLC (U.S. and Canada)
|
|
Distributed Products
|
|
|
|
|
|
|
|
|
||
|
|
|
Long-Term Care
|
|
Genworth Life Insurance Company and its
|
|
|
|
Insurance
|
|
affiliates (U.S.)
|
|
|
|
|
|
Various insurance companies, as offered through
|
|
|
|
|
|
LTCI Partners, LLC (U.S.)
|
|
|
|
|
||
|
|
|
Prepaid Legal Services
|
|
Pre-paid Legal Services, Inc. (U.S. and Canada)
|
|
|
|
|
|
|
|
|
|
Supplemental Health
|
|
The Edge Benefits Inc. (Canada)
|
|
|
|
and Accidental Death &
|
|
|
|
|
|
Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
|
Auto and Homeowners'
|
|
Various insurance companies, as offered through
|
|
|
|
Insurance
(1)
|
|
Answer Financial, Inc. (U.S.)
|
|
|
|
|
|
|
|
|
|
Debt Resolution Products
(1)
|
|
Freedom Financial Network, LLC (U.S.)
|
|
|
|
|
|
|
|
|
|
Mortgage Loan Referrals
(1)
|
|
B2B Bank (Canada)
|
|
|
|
|
||
|
|
|
Student Life Insurance
|
|
NBLIC (U.S., except Alaska, Hawaii, Montana, Washington and the District of Columbia)
|
|
|
|
|
||
|
|
|
Short-Term Disability
|
|
NBLIC (New York and New Jersey)
|
|
|
|
Benefit Insurance
|
|
|
|
(1)
|
Referrals only.
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
Life insurance issued:
|
|
|
|
|
|
|
||||||
|
Number of policies issued
|
|
214,617
|
|
|
222,558
|
|
|
237,535
|
|
|||
|
Face amount issued (in millions)
|
|
$
|
67,783
|
|
|
$
|
68,053
|
|
|
$
|
73,146
|
|
|
|
|
|||||||||||
|
|
|
December 31,
|
||||||||||
|
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
Life insurance in force:
|
|
|
|
|
|
|
||||||
|
Number of policies in force
|
|
2,320,824
|
|
|
2,317,679
|
|
|
2,316,131
|
|
|||
|
Face amount in force (in millions)
|
|
$
|
674,868
|
|
|
$
|
670,412
|
|
|
$
|
664,955
|
|
|
•
|
expected changes from relevant experience due to changes in circumstances, such as (i) revised underwriting procedures affecting future mortality and reinsurance rates, (ii) new product features, and (iii) revised administrative programs affecting sales levels, expenses, and client continuation or termination of policies; and
|
|
•
|
observed trends in experience that we expect to continue, such as general mortality improvement in the general population and better or worse policy persistency (the period over which a policy remains in force) due to changing economic conditions.
|
|
|
|
Year ended December 31,
|
||||||||||||
|
|
|
2013
|
|
|
2012
|
|
|
2011
|
||||||
|
|
|
(In thousands)
|
||||||||||||
|
Death
|
|
$
|
1,104,123
|
|
|
|
$
|
1,040,507
|
|
|
|
$
|
993,396
|
|
|
Waiver of premium
|
|
31,786
|
|
|
|
28,665
|
|
|
|
25,836
|
|
|||
|
Terminal illness
(1)
|
|
11,765
|
|
|
|
7,819
|
|
|
|
9,654
|
|
|||
|
(1)
|
We consider claims paid for terminal illness to be loans made to the beneficiary that are repaid to us upon death of the beneficiary from the death benefit.
|
|
|
Cash and Securities Dividends Paid or Payable
|
||||||||||
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(in thousands)
|
||||||||||
|
Primerica Life
|
$
|
150,000
|
|
|
$
|
150,000
|
|
|
$
|
200,000
|
|
|
Primerica Life Canada
|
14,387
|
|
|
15,100
|
|
|
—
|
|
|||
|
•
|
reducing sales of insurance products;
|
|
•
|
adversely affecting our relationships with our sales representatives;
|
|
•
|
materially increasing the amount of policy cancellations by our policyholders;
|
|
•
|
requiring us to reduce prices to remain competitive; and
|
|
•
|
adversely affecting our ability to obtain reinsurance at reasonable prices or at all.
|
|
Name
|
|
Age
|
|
Position
|
|
D. Richard Williams
|
|
57
|
|
Chairman of the Board and Co-Chief Executive Officer
|
|
John A. Addison, Jr.
|
|
56
|
|
Chairman of Primerica Distribution, Co-Chief Executive Officer and Director
|
|
Glenn J. Williams
|
|
54
|
|
President
|
|
Michael C. Adams
|
|
57
|
|
Executive Vice President and Chief Business Technology Officer
|
|
Chess E. Britt
|
|
57
|
|
Executive Vice President and Chief Marketing Officer
|
|
Jeffrey S. Fendler
|
|
57
|
|
Executive Vice President and Chief Compliance and Risk Officer
|
|
Gregory C. Pitts
|
|
51
|
|
Executive Vice President and Chief Operating Officer
|
|
Alison S. Rand
|
|
46
|
|
Executive Vice President and Chief Financial Officer
|
|
Peter W. Schneider
|
|
57
|
|
Executive Vice President, General Counsel and Chief Administrative Officer
|
|
William A. Kelly
|
|
58
|
|
President of PFS Investments
|
|
|
High
|
|
Low
|
|
Dividend
|
||||||
|
2013
|
|
|
|
|
|
||||||
|
4th quarter
|
$
|
44.22
|
|
|
$
|
38.74
|
|
|
$
|
0.11
|
|
|
3rd quarter
|
42.37
|
|
|
36.42
|
|
|
0.11
|
|
|||
|
2nd quarter
|
37.93
|
|
|
31.13
|
|
|
0.11
|
|
|||
|
1st quarter
|
34.35
|
|
|
30.38
|
|
|
0.11
|
|
|||
|
2012
|
|
|
|
|
|
||||||
|
4th quarter
|
$
|
30.08
|
|
|
$
|
27.22
|
|
|
$
|
0.09
|
|
|
3rd quarter
|
30.29
|
|
|
26.02
|
|
|
0.07
|
|
|||
|
2nd quarter
|
26.88
|
|
|
23.28
|
|
|
0.05
|
|
|||
|
1st quarter
|
26.15
|
|
|
22.92
|
|
|
0.03
|
|
|||
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans
|
|
||||
|
Equity compensation plans approved by stockholders:
|
|
|
|
|
|
|
||||
|
Primerica, Inc. Amended and Restated 2010 Omnibus Incentive Plan
|
1,225,658
|
|
(1)
|
$
|
32.63
|
|
(2)
|
2,757,378
|
|
(3)
|
|
Primerica, Inc. Stock Purchase Plan for Agents and Employees
|
—
|
|
|
—
|
|
|
2,167,432
|
|
(4)
|
|
|
|
|
|
|
|
|
|
||||
|
Total
|
1,225,658
|
|
|
$
|
32.63
|
|
|
4,924,810
|
|
|
|
|
|
|
|
|
|
|
||||
|
Equity compensation plans not approved by stockholders
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
|
|
(1)
|
Consists of
1,091,436
and
134,222
shares of our common stock to be issued in connection with outstanding restricted stock units ("RSUs") and options, respectively.
|
|
(2)
|
The options outstanding have a weighted average exercise price of
$32.63
.
|
|
(3)
|
The number of shares of our common stock available for future issuance is
10,800,000
less the cumulative number of awards granted under the plan plus the cumulative number of awards canceled under the plan.
|
|
(4)
|
The number of shares of our common stock available for future issuance is
2,500,000
less the cumulative number of shares issued under the plan.
|
|
|
Period Ended
|
|
|
||||||||||||||||||||||||
|
Index
|
04/01/10
|
|
06/30/10
|
|
12/31/10
|
|
06/30/11
|
|
12/31/11
|
|
06/30/12
|
|
12/31/12
|
|
06/30/13
|
|
12/31/13
|
|
|||||||||
|
Primerica Inc.
|
$
|
100.00
|
|
$
|
142.93
|
|
$
|
161.82
|
|
$
|
146.87
|
|
$
|
155.80
|
|
$
|
179.79
|
|
$
|
202.98
|
|
$
|
254.93
|
|
$
|
293.78
|
|
|
S&P 500 Insurance
|
100.00
|
|
90.50
|
|
102.59
|
|
102.39
|
|
94.09
|
|
101.19
|
|
112.05
|
|
139.26
|
|
164.39
|
|
|||||||||
|
S&P MidCap 400
|
100.00
|
|
89.57
|
|
115.00
|
|
124.85
|
|
113.01
|
|
121.94
|
|
133.22
|
|
152.65
|
|
177.84
|
|
|||||||||
|
Russell 2000
|
100.00
|
|
89.37
|
|
115.63
|
|
122.81
|
|
110.80
|
|
120.25
|
|
128.92
|
|
149.36
|
|
178.97
|
|
|||||||||
|
|
Year ended December 31,
|
||||||||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
||||||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||||||||||
|
Statements of income data
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Direct premiums
|
$
|
2,302,069
|
|
|
$
|
2,267,975
|
|
|
$
|
2,229,467
|
|
|
$
|
2,181,074
|
|
|
$
|
2,112,781
|
|
|
Ceded premiums
|
(1,644,158
|
)
|
|
(1,663,753
|
)
|
|
(1,703,075
|
)
|
|
(1,450,367
|
)
|
|
(610,754
|
)
|
|||||
|
Net premiums
|
657,911
|
|
|
604,222
|
|
|
526,392
|
|
|
730,707
|
|
|
1,502,027
|
|
|||||
|
Commission and fees
|
471,808
|
|
|
429,044
|
|
|
414,471
|
|
|
383,984
|
|
|
336,822
|
|
|||||
|
Net investment income
|
88,752
|
|
|
100,804
|
|
|
108,601
|
|
|
165,111
|
|
|
351,326
|
|
|||||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
6,246
|
|
|
11,382
|
|
|
6,440
|
|
|
34,145
|
|
|
(21,970
|
)
|
|||||
|
Other, net
|
42,731
|
|
|
45,263
|
|
|
47,189
|
|
|
47,916
|
|
|
52,196
|
|
|||||
|
Total revenues
|
1,267,448
|
|
|
1,190,715
|
|
|
1,103,093
|
|
|
1,361,863
|
|
|
2,220,401
|
|
|||||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Benefits and claims
|
301,475
|
|
|
278,747
|
|
|
242,696
|
|
|
317,703
|
|
|
600,273
|
|
|||||
|
Amortization of deferred policy acquisition costs
|
129,183
|
|
|
118,598
|
|
|
104,034
|
|
|
147,841
|
|
|
352,257
|
|
|||||
|
Sales commissions
|
232,237
|
|
|
204,569
|
|
|
191,722
|
|
|
180,054
|
|
|
162,756
|
|
|||||
|
Insurance expenses
|
108,658
|
|
|
96,541
|
|
|
89,192
|
|
|
105,132
|
|
|
179,592
|
|
|||||
|
Insurance commissions
|
22,471
|
|
|
27,555
|
|
|
38,618
|
|
|
48,182
|
|
|
50,750
|
|
|||||
|
Interest expense
|
35,018
|
|
|
33,101
|
|
|
27,968
|
|
|
20,872
|
|
|
—
|
|
|||||
|
Other operating expenses
|
187,208
|
|
|
164,716
|
|
|
164,954
|
|
|
180,610
|
|
|
132,978
|
|
|||||
|
Total benefits and expenses
|
1,016,250
|
|
|
923,827
|
|
|
859,184
|
|
|
1,000,394
|
|
|
1,478,606
|
|
|||||
|
Income before income taxes
|
251,198
|
|
|
266,888
|
|
|
243,909
|
|
|
361,469
|
|
|
741,795
|
|
|||||
|
Income taxes
|
88,473
|
|
|
93,082
|
|
|
86,718
|
|
|
129,013
|
|
|
259,114
|
|
|||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
$
|
232,456
|
|
|
$
|
482,681
|
|
|
Earnings per share — basic
|
$
|
2.87
|
|
|
$
|
2.77
|
|
|
$
|
2.11
|
|
|
$
|
3.09
|
|
(1)
|
n/a
|
|
|
|
Earnings per share — diluted
|
$
|
2.83
|
|
|
$
|
2.71
|
|
|
$
|
2.08
|
|
|
$
|
3.06
|
|
(1)
|
n/a
|
|
|
|
Dividends per common share
|
$
|
0.44
|
|
|
$
|
0.24
|
|
|
$
|
0.10
|
|
|
$
|
0.02
|
|
|
n/a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Balance sheet data
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Investments
|
$
|
1,835,403
|
|
|
$
|
1,956,536
|
|
|
$
|
2,021,504
|
|
|
$
|
2,153,584
|
|
|
$
|
6,471,448
|
|
|
Cash and cash equivalents
|
149,189
|
|
|
112,216
|
|
|
136,078
|
|
|
126,038
|
|
|
602,522
|
|
|||||
|
Due from reinsurers
|
4,055,054
|
|
|
4,005,194
|
|
|
3,855,318
|
|
|
3,731,002
|
|
|
851,635
|
|
|||||
|
Deferred policy acquisition costs, net
|
1,208,466
|
|
|
1,066,422
|
|
|
904,485
|
|
|
738,946
|
|
|
2,520,251
|
|
|||||
|
Total assets
|
10,329,950
|
|
|
10,337,877
|
|
|
9,851,820
|
|
|
9,769,409
|
|
|
13,429,883
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Future policy benefits
|
5,063,103
|
|
|
4,850,488
|
|
|
4,614,860
|
|
|
4,409,183
|
|
|
4,197,454
|
|
|||||
|
Notes payable
|
374,481
|
|
|
374,433
|
|
|
300,000
|
|
|
300,000
|
|
|
—
|
|
|||||
|
Total liabilities
|
9,107,923
|
|
|
9,062,461
|
|
|
8,525,170
|
|
|
8,412,881
|
|
|
8,662,612
|
|
|||||
|
Stockholders' equity
|
1,222,027
|
|
|
1,275,416
|
|
|
1,326,650
|
|
|
1,356,528
|
|
|
4,767,271
|
|
|||||
|
(1)
|
Calculated on a pro forma basis using weighted-average shares, including the shares issued or issuable upon lapse of restrictions following our April 1, 2010 corporate reorganization as though they had been issued and outstanding on January 1, 2010.
|
|
•
|
Business Trends and Conditions
|
|
•
|
Factors Affecting Our Results
|
|
•
|
Critical Accounting Estimates
|
|
•
|
Results of Operations
|
|
•
|
Financial Condition
|
|
•
|
Liquidity and Capital Resources
|
|
|
Year ended December 31,
|
|
|||||||
|
|
2013
|
|
2012
|
|
2011
|
|
|||
|
Average number of life-licensed sales representatives
|
93,086
|
|
|
90,981
|
|
|
91,855
|
|
|
|
Number of new policies issued
|
214,617
|
|
|
222,558
|
|
|
237,535
|
|
|
|
Average monthly rate of new policies issued per life-licensed sales representative
|
.19x
|
|
|
.20x
|
|
|
.22x
|
|
(1)
|
|
(1)
|
Our 2011 processing cycle provided five additional days of policy processing. Excluding the policies processed during these additional days, the average monthly rate of new policies issued per life licensed sales representative would have been
0.21x
for 2011.
|
|
•
|
Persistency
. Persistency is a measure of how long our insurance policies stay in force. As a general matter, persistency that is lower than our pricing assumptions adversely affects our results over the long term because we
|
|
•
|
Mortality.
Our profitability will fluctuate to the extent actual mortality rates differ from those used in our pricing assumptions. We mitigate a significant portion of our mortality exposure through reinsurance.
|
|
•
|
Investment Yields.
We use investment yield rates based on yields available at the time a policy is issued. For policies issued in 2010 and later, we have been using an increasing interest rate assumption to reflect the historically low interest rate environment. Both DAC and the future policy benefit reserve liability increase with the assumed investment yield rate. Because DAC is higher than the future policy benefit reserve liability in the early years of a policy, a lower assumed investment yield generally will result in lower profits. In the later years, when the future policy benefit reserve liability is higher than DAC, a lower assumed investment yield generally will result in higher profits. These assumed investment yields, which like other pricing assumptions are locked in at issue, impact the timing but not the aggregate amount of DAC and future policy benefit reserve changes. Actual investment yields will impact net investment income allocated to the Term Life Insurance segment, but will not impact DAC or the future policy benefit reserve liability.
|
|
•
|
Ceded premiums.
Ceded premiums are the premiums we pay to reinsurers. These amounts are deducted from the direct premiums we earn to calculate our net premium revenues. Similar to direct premium revenues, ceded coinsurance premiums remain level over the initial term of the insurance policy. Ceded YRT premiums increase over the period that the policy has been in force. Accordingly, ceded YRT premiums generally constitute an increasing percentage of direct premiums over the policy term.
|
|
•
|
Benefits and claims.
Benefits and claims include incurred claim amounts and changes in future policy benefit reserves. Reinsurance reduces incurred claims in direct proportion to the percentage ceded. Coinsurance also reduces the change in future policy benefit reserves in direct proportion to the percentage ceded, while YRT reinsurance does not significantly impact the change in these reserves.
|
|
•
|
Amortization of DAC.
DAC, and therefore amortization of DAC, is reduced on a pro-rata basis for the coinsured business, including the business reinsured with Citigroup. There is no impact on amortization of DAC associated with our YRT contracts.
|
|
•
|
Insurance expenses.
Insurance expenses are reduced by the allowances received from coinsurance, including the business reinsured with Citigroup. There is no impact on insurance expenses associated with our YRT contracts.
|
|
•
|
sales of annuity products in the United States will generate higher revenues in the period such sales occur than sales of other investment products that either generate lower upfront revenues or, in the case of managed accounts and segregated funds, no upfront revenues;
|
|
•
|
sales of a higher proportion of managed accounts and segregated funds products will generally extend the time over which revenues can be earned because we are entitled to higher revenues based on assets under management for these accounts in lieu of upfront revenues; and
|
|
•
|
sales of a higher proportion of mutual fund products and the composition of the fund families sold will impact the timing and amount of revenue we earn given the marketing, support, recordkeeping and custodial services we perform for the various mutual fund products we distribute.
|
|
•
|
Net premiums.
Reflects direct premiums payable by our policyholders on our in-force insurance policies, primarily term life insurance, net of reinsurance premiums that we pay to reinsurers.
|
|
•
|
Commissions and fees.
Consists primarily of dealer re-allowances earned on the sales of investment and savings products, trail commissions and management fees based on the asset values of client accounts, marketing and support fees from product originators, custodial fees for services rendered in our capacity as nominee on client retirement accounts funded by mutual funds on our servicing platform, recordkeeping fees for mutual funds on our servicing platform and fees associated with the sale of other distributed products.
|
|
•
|
Net investment income.
Represents income, net of investment-related expenses, generated by our invested asset portfolio, which consists primarily of interest income earned on fixed-maturity investments. Investment income earned on assets supporting our statutory reserves and targeted capital is allocated to our Term Life Insurance segment, with the balance included in our Corporate and Other Distributed Products segment.
|
|
•
|
Realized investment gains (losses), including other-than-temporary impairments (“OTTI”).
Reflects the difference between amortized cost and amounts realized on the sale of invested assets, as well as OTTI charges.
|
|
•
|
Other, net.
Reflects revenues generated primarily from the fees charged for access to our sales force support applications, as well as revenues from the sale of marketing materials and other miscellaneous items.
|
|
•
|
Benefits and claims.
Reflects the benefits and claims payable on insurance policies, as well as changes in our reserves for future policy claims and reserves for other benefits payable, net of reinsurance.
|
|
•
|
Amortization of DAC.
Represents the amortization of capitalized costs associated with the sale of an insurance policy or segregated fund, including sales commissions, medical examination and other underwriting costs, and other policy issuance costs.
|
|
•
|
Insurance commissions.
Reflects sales commissions in respect of insurance products that are not eligible for deferral.
|
|
•
|
Insurance expenses.
Reflects non-capitalized insurance expenses, including staff compensation, technology and communications, insurance sales force-related costs, printing, postage and distribution of insurance sales materials, outsourcing and professional fees, premium taxes, amortization of certain intangibles and other corporate and administrative fees and expenses related to our insurance operations.
|
|
•
|
Sales commissions.
Represents commissions to our sales representatives in connection with the sale of investment and savings products and products other than insurance products.
|
|
•
|
Interest expense.
Reflects interest on the Senior Notes, the financing charges related to an issued letter of credit, and a finance charge incurred pursuant to our coinsurance agreement with Citigroup.
|
|
•
|
Other operating expenses.
Consists primarily of expenses that are unrelated to the distribution of insurance products, including staff compensation, technology and communications, various sales force-related costs, printing, postage and distribution of sales materials, outsourcing and professional fees, amortization of certain intangibles and other corporate and administrative fees and expenses.
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
2,302,069
|
|
|
$
|
2,267,975
|
|
|
$
|
34,094
|
|
|
2
|
%
|
|
Ceded premiums
|
(1,644,158
|
)
|
|
(1,663,753
|
)
|
|
(19,595
|
)
|
|
(1
|
)%
|
|||
|
Net premiums
|
657,911
|
|
|
604,222
|
|
|
53,689
|
|
|
9
|
%
|
|||
|
Commissions and fees
|
471,808
|
|
|
429,044
|
|
|
42,764
|
|
|
10
|
%
|
|||
|
Net investment income
|
88,752
|
|
|
100,804
|
|
|
(12,052
|
)
|
|
(12
|
)%
|
|||
|
Realized investment gains, including OTTI
|
6,246
|
|
|
11,382
|
|
|
(5,136
|
)
|
|
(45
|
)%
|
|||
|
Other, net
|
42,731
|
|
|
45,263
|
|
|
(2,532
|
)
|
|
(6
|
)%
|
|||
|
Total revenues
|
1,267,448
|
|
|
1,190,715
|
|
|
76,733
|
|
|
6
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
301,475
|
|
|
278,747
|
|
|
22,728
|
|
|
8
|
%
|
|||
|
Amortization of DAC
|
129,183
|
|
|
118,598
|
|
|
10,585
|
|
|
9
|
%
|
|||
|
Sales commissions
|
232,237
|
|
|
204,569
|
|
|
27,668
|
|
|
14
|
%
|
|||
|
Insurance expenses
|
108,658
|
|
|
96,541
|
|
|
12,117
|
|
|
13
|
%
|
|||
|
Insurance commissions
|
22,471
|
|
|
27,555
|
|
|
(5,084
|
)
|
|
(18
|
)%
|
|||
|
Interest expense
|
35,018
|
|
|
33,101
|
|
|
1,917
|
|
|
6
|
%
|
|||
|
Other operating expenses
|
187,208
|
|
|
164,716
|
|
|
22,492
|
|
|
14
|
%
|
|||
|
Total benefits and expenses
|
1,016,250
|
|
|
923,827
|
|
|
92,423
|
|
|
10
|
%
|
|||
|
Income before income taxes
|
251,198
|
|
|
266,888
|
|
|
(15,690
|
)
|
|
(6
|
)%
|
|||
|
Income taxes
|
88,473
|
|
|
93,082
|
|
|
(4,609
|
)
|
|
(5
|
)%
|
|||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
(11,081
|
)
|
|
(6
|
)%
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
2,229,204
|
|
|
$
|
2,193,280
|
|
|
$
|
35,924
|
|
|
2
|
%
|
|
Ceded premiums
|
(1,632,042
|
)
|
|
(1,649,622
|
)
|
|
(17,580
|
)
|
|
(1
|
)%
|
|||
|
Net premiums
|
597,162
|
|
|
543,658
|
|
|
53,504
|
|
|
10
|
%
|
|||
|
Allocated net investment income
|
68,796
|
|
|
66,119
|
|
|
2,677
|
|
|
4
|
%
|
|||
|
Other, net
|
29,017
|
|
|
30,357
|
|
|
(1,340
|
)
|
|
(4
|
)%
|
|||
|
Total revenues
|
694,975
|
|
|
640,134
|
|
|
54,841
|
|
|
9
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
262,357
|
|
|
239,346
|
|
|
23,011
|
|
|
10
|
%
|
|||
|
Amortization of DAC
|
115,891
|
|
|
104,272
|
|
|
11,619
|
|
|
11
|
%
|
|||
|
Insurance expenses
|
98,081
|
|
|
85,156
|
|
|
12,925
|
|
|
15
|
%
|
|||
|
Insurance commissions
|
4,599
|
|
|
9,599
|
|
|
(5,000
|
)
|
|
(52
|
)%
|
|||
|
Interest expense
|
16,846
|
|
|
15,835
|
|
|
1,011
|
|
|
6
|
%
|
|||
|
Total benefits and expenses
|
497,774
|
|
|
454,208
|
|
|
43,566
|
|
|
10
|
%
|
|||
|
Income before income taxes
|
$
|
197,201
|
|
|
$
|
185,926
|
|
|
$
|
11,275
|
|
|
6
|
%
|
|
|
|
Year ended December 31,
|
||||||||||||
|
|
|
2013
|
|
% of beginning balance
|
|
2012
|
|
% of beginning balance
|
||||||
|
|
|
(Dollars in millions)
|
||||||||||||
|
Face amount in force, beginning of period
|
|
$
|
670,412
|
|
|
|
|
$
|
664,955
|
|
|
|
||
|
Net change in face amount:
|
|
|
|
|
|
|
|
|
||||||
|
Issued face amount
|
|
67,783
|
|
|
10
|
%
|
|
68,053
|
|
|
10
|
%
|
||
|
Terminations
|
|
(57,730
|
)
|
|
(9
|
)%
|
|
(61,593
|
)
|
|
(9
|
)%
|
||
|
Foreign currency
|
|
(5,597
|
)
|
|
(1
|
)%
|
|
(1,003
|
)
|
|
*
|
|||
|
Net change in face amount
|
|
4,456
|
|
|
1
|
%
|
|
5,457
|
|
|
1
|
%
|
||
|
Face amount in force, end of period
|
|
$
|
674,868
|
|
|
|
|
$
|
670,412
|
|
|
|
||
|
*
|
Less than 1%.
|
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|||||||
|
Commissions and fees:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales-based revenues
|
|
$
|
208,319
|
|
|
$
|
186,267
|
|
|
$
|
22,052
|
|
|
12
|
%
|
|
Asset-based revenues
|
|
201,276
|
|
|
179,725
|
|
|
21,551
|
|
|
12
|
%
|
|||
|
Account-based revenues
|
|
38,868
|
|
|
38,510
|
|
|
358
|
|
|
1
|
%
|
|||
|
Other, net
|
|
8,675
|
|
|
9,463
|
|
|
(788
|
)
|
|
(8
|
)%
|
|||
|
Total revenues
|
|
457,138
|
|
|
413,965
|
|
|
43,173
|
|
|
10
|
%
|
|||
|
Expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
Amortization of DAC
|
|
11,195
|
|
|
10,956
|
|
|
239
|
|
|
2
|
%
|
|||
|
Insurance commissions
|
|
9,046
|
|
|
9,070
|
|
|
(24
|
)
|
|
*
|
||||
|
Sales commissions:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales-based
|
|
146,652
|
|
|
129,914
|
|
|
16,738
|
|
|
13
|
%
|
|||
|
Asset-based
|
|
73,146
|
|
|
61,491
|
|
|
11,655
|
|
|
19
|
%
|
|||
|
Other operating expenses
|
|
111,950
|
|
|
81,418
|
|
|
30,532
|
|
|
38
|
%
|
|||
|
Total expenses
|
|
351,989
|
|
|
292,849
|
|
|
59,140
|
|
|
20
|
%
|
|||
|
Income before income taxes
|
|
$
|
105,149
|
|
|
$
|
121,116
|
|
|
$
|
(15,967
|
)
|
|
(13
|
)%
|
|
*
|
Less than 1%.
|
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in millions and accounts in thousands)
|
|||||||||||||
|
Product sales:
|
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
|
$
|
2,766
|
|
|
$
|
2,346
|
|
|
$
|
420
|
|
|
18
|
%
|
|
Annuities and other
|
|
1,935
|
|
|
1,902
|
|
|
33
|
|
|
2
|
%
|
|||
|
Total sales-based revenue generating product sales
|
|
4,701
|
|
|
4,248
|
|
|
453
|
|
|
11
|
%
|
|||
|
Segregated funds
|
|
283
|
|
|
328
|
|
|
(45
|
)
|
|
(14
|
)%
|
|||
|
Managed accounts
|
|
225
|
|
|
136
|
|
|
89
|
|
|
65
|
%
|
|||
|
Total product sales
|
|
$
|
5,209
|
|
|
$
|
4,712
|
|
|
$
|
497
|
|
|
11
|
%
|
|
Average client asset values:
|
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
|
$
|
27,284
|
|
|
$
|
24,214
|
|
|
$
|
3,070
|
|
|
13
|
%
|
|
Annuities and other
|
|
11,175
|
|
|
9,149
|
|
|
2,026
|
|
|
22
|
%
|
|||
|
Segregated funds
|
|
2,576
|
|
|
2,541
|
|
|
35
|
|
|
1
|
%
|
|||
|
Total average asset values in client accounts
|
|
$
|
41,035
|
|
|
$
|
35,904
|
|
|
$
|
5,131
|
|
|
14
|
%
|
|
Average number of fee-generating accounts:
|
|
|
|
|
|
|
|
|
|||||||
|
Recordkeeping accounts
|
|
2,540
|
|
|
2,567
|
|
|
(27
|
)
|
|
(1
|
)%
|
|||
|
Custodial accounts
|
|
1,954
|
|
|
1,945
|
|
|
9
|
|
|
*
|
||||
|
*
|
Less than 1%.
|
|
|
|
Year ended December 31,
|
||||||||||||
|
|
|
2013
|
|
% of beginning balance
|
|
2012
|
|
% of beginning balance
|
||||||
|
|
|
(Dollars in millions)
|
||||||||||||
|
Asset values, beginning of period
|
|
$
|
37,386
|
|
|
|
|
$
|
33,664
|
|
|
|
||
|
Net change in asset values:
|
|
|
|
|
|
|
|
|
||||||
|
Inflows
|
|
5,209
|
|
|
14
|
%
|
|
4,712
|
|
|
14
|
%
|
||
|
Redemptions
|
|
(4,825
|
)
|
|
(13
|
)%
|
|
(4,442
|
)
|
|
(13
|
)%
|
||
|
Change in market value, net and other
|
|
7,220
|
|
|
19
|
%
|
|
3,452
|
|
|
10
|
%
|
||
|
Net change in asset values
|
|
7,604
|
|
|
20
|
%
|
|
3,722
|
|
|
11
|
%
|
||
|
Asset values, end of period
|
|
$
|
44,990
|
|
|
|
|
$
|
37,386
|
|
|
|
||
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
|
$
|
72,865
|
|
|
$
|
74,695
|
|
|
$
|
(1,830
|
)
|
|
(2
|
)%
|
|
Ceded premiums
|
|
(12,116
|
)
|
|
(14,131
|
)
|
|
(2,015
|
)
|
|
(14
|
)%
|
|||
|
Net premiums
|
|
60,749
|
|
|
60,564
|
|
|
185
|
|
|
*
|
||||
|
Commissions and fees
|
|
23,345
|
|
|
24,542
|
|
|
(1,197
|
)
|
|
(5
|
)%
|
|||
|
Allocated net investment income
|
|
19,956
|
|
|
34,685
|
|
|
(14,729
|
)
|
|
(42
|
)%
|
|||
|
Realized investment gains, including OTTI
|
|
6,246
|
|
|
11,382
|
|
|
(5,136
|
)
|
|
(45
|
)%
|
|||
|
Other, net
|
|
5,039
|
|
|
5,443
|
|
|
(404
|
)
|
|
(7
|
)%
|
|||
|
Total revenues
|
|
115,335
|
|
|
136,616
|
|
|
(21,281
|
)
|
|
(16
|
)%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
|
39,118
|
|
|
39,401
|
|
|
(283
|
)
|
|
(1
|
)%
|
|||
|
Amortization of DAC
|
|
2,097
|
|
|
3,370
|
|
|
(1,273
|
)
|
|
(38
|
)%
|
|||
|
Sales commissions
|
|
12,439
|
|
|
13,164
|
|
|
(725
|
)
|
|
(6
|
)%
|
|||
|
Insurance expenses
|
|
10,577
|
|
|
11,385
|
|
|
(808
|
)
|
|
(7
|
)%
|
|||
|
Insurance commissions
|
|
8,826
|
|
|
8,886
|
|
|
(60
|
)
|
|
(1
|
)%
|
|||
|
Interest expense
|
|
18,172
|
|
|
17,266
|
|
|
906
|
|
|
5
|
%
|
|||
|
Other operating expenses
|
|
75,258
|
|
|
83,298
|
|
|
(8,040
|
)
|
|
(10
|
)%
|
|||
|
Total benefits and expenses
|
|
166,487
|
|
|
176,770
|
|
|
(10,283
|
)
|
|
(6
|
)%
|
|||
|
Loss before income taxes
|
|
$
|
(51,152
|
)
|
|
$
|
(40,154
|
)
|
|
$
|
10,998
|
|
|
27
|
%
|
|
*
|
Less than 1%.
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
2012
|
|
2011
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
2,267,975
|
|
|
$
|
2,229,467
|
|
|
$
|
38,508
|
|
|
2
|
%
|
|
Ceded premiums
|
(1,663,753
|
)
|
|
(1,703,075
|
)
|
|
(39,322
|
)
|
|
(2
|
)%
|
|||
|
Net premiums
|
604,222
|
|
|
526,392
|
|
|
77,830
|
|
|
15
|
%
|
|||
|
Commissions and fees
|
429,044
|
|
|
414,471
|
|
|
14,573
|
|
|
4
|
%
|
|||
|
Net investment income
|
100,804
|
|
|
108,601
|
|
|
(7,797
|
)
|
|
(7
|
)%
|
|||
|
Realized investment gains, including OTTI
|
11,382
|
|
|
6,440
|
|
|
4,942
|
|
|
77
|
%
|
|||
|
Other, net
|
45,263
|
|
|
47,189
|
|
|
(1,926
|
)
|
|
(4
|
)%
|
|||
|
Total revenues
|
1,190,715
|
|
|
1,103,093
|
|
|
87,622
|
|
|
8
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
278,747
|
|
|
242,696
|
|
|
36,051
|
|
|
15
|
%
|
|||
|
Amortization of DAC
|
118,598
|
|
|
104,034
|
|
|
14,564
|
|
|
14
|
%
|
|||
|
Sales commissions
|
204,569
|
|
|
191,722
|
|
|
12,847
|
|
|
7
|
%
|
|||
|
Insurance expenses
|
96,541
|
|
|
89,192
|
|
|
7,349
|
|
|
8
|
%
|
|||
|
Insurance commissions
|
27,555
|
|
|
38,618
|
|
|
(11,063
|
)
|
|
(29
|
)%
|
|||
|
Interest expense
|
33,101
|
|
|
27,968
|
|
|
5,133
|
|
|
18
|
%
|
|||
|
Other operating expenses
|
164,716
|
|
|
164,954
|
|
|
(238
|
)
|
|
*
|
||||
|
Total benefits and expenses
|
923,827
|
|
|
859,184
|
|
|
64,643
|
|
|
8
|
%
|
|||
|
Income before income taxes
|
266,888
|
|
|
243,909
|
|
|
22,979
|
|
|
9
|
%
|
|||
|
Income taxes
|
93,082
|
|
|
86,718
|
|
|
6,364
|
|
|
7
|
%
|
|||
|
Net income
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
$
|
16,615
|
|
|
11
|
%
|
|
*
|
Less than 1%.
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
2012
|
|
2011
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
2,193,280
|
|
|
$
|
2,149,594
|
|
|
$
|
43,686
|
|
|
2
|
%
|
|
Ceded premiums
|
(1,649,622
|
)
|
|
(1,688,953
|
)
|
|
(39,331
|
)
|
|
(2
|
)%
|
|||
|
Net premiums
|
543,658
|
|
|
460,641
|
|
|
83,017
|
|
|
18
|
%
|
|||
|
Allocated net investment income
|
66,119
|
|
|
60,668
|
|
|
5,451
|
|
|
9
|
%
|
|||
|
Other, net
|
30,357
|
|
|
31,666
|
|
|
(1,309
|
)
|
|
(4
|
)%
|
|||
|
Total revenues
|
640,134
|
|
|
552,975
|
|
|
87,159
|
|
|
16
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
239,346
|
|
|
197,159
|
|
|
42,187
|
|
|
21
|
%
|
|||
|
Amortization of DAC
|
104,272
|
|
|
89,474
|
|
|
14,798
|
|
|
17
|
%
|
|||
|
Insurance expenses
|
85,156
|
|
|
75,048
|
|
|
10,108
|
|
|
13
|
%
|
|||
|
Insurance commissions
|
9,599
|
|
|
19,396
|
|
|
(9,797
|
)
|
|
(51
|
)%
|
|||
|
Interest expense
|
15,835
|
|
|
11,467
|
|
|
4,368
|
|
|
38
|
%
|
|||
|
Total benefits and expenses
|
454,208
|
|
|
392,544
|
|
|
61,664
|
|
|
16
|
%
|
|||
|
Income before income taxes
|
$
|
185,926
|
|
|
$
|
160,431
|
|
|
$
|
25,495
|
|
|
16
|
%
|
|
|
|
Year ended December 31,
|
||||||||||||
|
|
|
2012
|
|
% of beginning balance
|
|
2011
|
|
% of beginning balance
|
||||||
|
|
|
(Dollars in millions)
|
||||||||||||
|
Face amount in force, beginning of period
|
|
$
|
664,955
|
|
|
|
|
$
|
656,791
|
|
|
|
||
|
Net change in face amount:
|
|
|
|
|
|
|
|
|
||||||
|
Issued face amount
|
|
68,053
|
|
|
10
|
%
|
|
73,146
|
|
|
11
|
%
|
||
|
Terminations
|
|
(61,593
|
)
|
|
(9
|
)%
|
|
(66,951
|
)
|
|
(10
|
)%
|
||
|
Foreign currency
|
|
(1,003
|
)
|
|
*
|
|
1,969
|
|
|
*
|
||||
|
Net change in face amount
|
|
5,457
|
|
|
1
|
%
|
|
8,164
|
|
|
1
|
%
|
||
|
Face amount in force, end of period
|
|
$
|
670,412
|
|
|
|
|
$
|
664,955
|
|
|
|
||
|
*
|
Less than 1%.
|
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2012
|
|
2011
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|||||||
|
Commissions and fees:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales-based revenues
|
|
$
|
186,267
|
|
|
$
|
171,854
|
|
|
$
|
14,413
|
|
|
8
|
%
|
|
Asset-based revenues
|
|
179,725
|
|
|
173,059
|
|
|
6,666
|
|
|
4
|
%
|
|||
|
Account-based revenues
|
|
38,510
|
|
|
41,997
|
|
|
(3,487
|
)
|
|
(8
|
)%
|
|||
|
Other, net
|
|
9,463
|
|
|
9,793
|
|
|
(330
|
)
|
|
(3
|
)%
|
|||
|
Total revenues
|
|
413,965
|
|
|
396,703
|
|
|
17,262
|
|
|
4
|
%
|
|||
|
Expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
Amortization of DAC
|
|
10,956
|
|
|
12,482
|
|
|
(1,526
|
)
|
|
(12
|
)%
|
|||
|
Insurance commissions
|
|
9,070
|
|
|
8,851
|
|
|
219
|
|
|
2
|
%
|
|||
|
Sales commissions:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales-based
|
|
129,914
|
|
|
118,387
|
|
|
11,527
|
|
|
10
|
%
|
|||
|
Asset-based
|
|
61,491
|
|
|
57,901
|
|
|
3,590
|
|
|
6
|
%
|
|||
|
Other operating expenses
|
|
81,418
|
|
|
82,006
|
|
|
(588
|
)
|
|
(1
|
)%
|
|||
|
Total expenses
|
|
292,849
|
|
|
279,627
|
|
|
13,222
|
|
|
5
|
%
|
|||
|
Income before income taxes
|
|
$
|
121,116
|
|
|
$
|
117,076
|
|
|
$
|
4,040
|
|
|
3
|
%
|
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2012
|
|
2011
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in millions and accounts in thousands)
|
|||||||||||||
|
Product sales:
|
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
|
$
|
2,346
|
|
|
$
|
2,230
|
|
|
$
|
116
|
|
|
5
|
%
|
|
Annuities and other
|
|
1,902
|
|
|
1,674
|
|
|
228
|
|
|
14
|
%
|
|||
|
Total sales-based revenue generating product sales
|
|
4,248
|
|
|
3,904
|
|
|
344
|
|
|
9
|
%
|
|||
|
Segregated funds
|
|
328
|
|
|
332
|
|
|
(4
|
)
|
|
(1
|
)%
|
|||
|
Managed accounts
|
|
136
|
|
|
29
|
|
|
107
|
|
|
*
|
||||
|
Total product sales
|
|
$
|
4,712
|
|
|
$
|
4,265
|
|
|
$
|
447
|
|
|
10
|
%
|
|
Average client asset values:
|
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
|
$
|
24,214
|
|
|
$
|
24,105
|
|
|
$
|
109
|
|
|
*
|
|
|
Annuities and other
|
|
9,149
|
|
|
8,276
|
|
|
873
|
|
|
11
|
%
|
|||
|
Segregated funds
|
|
2,541
|
|
|
2,489
|
|
|
52
|
|
|
2
|
%
|
|||
|
Total average asset values in client accounts
|
|
$
|
35,904
|
|
|
$
|
34,870
|
|
|
$
|
1,034
|
|
|
3
|
%
|
|
Average number of fee-generating accounts:
|
|
|
|
|
|
|
|
|
|||||||
|
Recordkeeping accounts
|
|
2,567
|
|
|
2,627
|
|
|
(60
|
)
|
|
(2
|
)%
|
|||
|
Custodial accounts
|
|
1,945
|
|
|
1,956
|
|
|
(11
|
)
|
|
(1
|
)%
|
|||
|
*
|
Less than 1% or not meaningful.
|
|
|
|
Year ended December 31,
|
||||||||||||
|
|
|
2012
|
|
% of beginning balance
|
|
2011
|
|
% of beginning balance
|
||||||
|
|
|
(Dollars in millions)
|
||||||||||||
|
Asset values, beginning of period
|
|
$
|
33,664
|
|
|
|
|
$
|
34,869
|
|
|
|
||
|
Net change in asset values:
|
|
|
|
|
|
|
|
|
||||||
|
Inflows
|
|
4,712
|
|
|
14
|
%
|
|
4,265
|
|
|
12
|
%
|
||
|
Redemptions
|
|
(4,442
|
)
|
|
(13
|
)%
|
|
(4,275
|
)
|
|
(12
|
)%
|
||
|
Change in market value, net and other
|
|
3,452
|
|
|
10
|
%
|
|
(1,195
|
)
|
|
(3
|
)%
|
||
|
Net change in asset values
|
|
3,722
|
|
|
11
|
%
|
|
(1,205
|
)
|
|
(3
|
)%
|
||
|
Asset values, end of period
|
|
$
|
37,386
|
|
|
|
|
$
|
33,664
|
|
|
|
||
|
|
|
Year ended December 31,
|
|
Change
|
|||||||||||
|
|
|
2012
|
|
2011
|
|
$
|
|
%
|
|||||||
|
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
|
$
|
74,695
|
|
|
$
|
79,873
|
|
|
$
|
(5,178
|
)
|
|
6%
|
|
|
Ceded premiums
|
|
(14,131
|
)
|
|
(14,122
|
)
|
|
9
|
|
|
*
|
||||
|
Net premiums
|
|
60,564
|
|
|
65,751
|
|
|
(5,187
|
)
|
|
8%
|
||||
|
Commissions and fees
|
|
24,542
|
|
|
27,561
|
|
|
(3,019
|
)
|
|
(11
|
)%
|
|||
|
Allocated net investment income
|
|
34,685
|
|
|
47,933
|
|
|
(13,248
|
)
|
|
(28
|
)%
|
|||
|
Realized investment gains, including OTTI
|
|
11,382
|
|
|
6,440
|
|
|
4,942
|
|
|
77
|
%
|
|||
|
Other, net
|
|
5,443
|
|
|
5,730
|
|
|
(287
|
)
|
|
(5
|
)%
|
|||
|
Total revenues
|
|
136,616
|
|
|
153,415
|
|
|
(16,799
|
)
|
|
(11
|
)%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
|
39,401
|
|
|
45,537
|
|
|
(6,136
|
)
|
|
(13
|
)%
|
|||
|
Amortization of DAC
|
|
3,370
|
|
|
2,078
|
|
|
1,292
|
|
|
62
|
%
|
|||
|
Sales commissions
|
|
13,164
|
|
|
15,434
|
|
|
(2,270
|
)
|
|
(15
|
)%
|
|||
|
Insurance expenses
|
|
11,385
|
|
|
14,144
|
|
|
(2,759
|
)
|
|
(20
|
)%
|
|||
|
Insurance commissions
|
|
8,886
|
|
|
10,371
|
|
|
(1,485
|
)
|
|
(14
|
)%
|
|||
|
Interest expense
|
|
17,266
|
|
|
16,501
|
|
|
765
|
|
|
5
|
%
|
|||
|
Other operating expenses
|
|
83,298
|
|
|
82,948
|
|
|
350
|
|
|
*
|
|
|||
|
Total benefits and expenses
|
|
176,770
|
|
|
187,013
|
|
|
(10,243
|
)
|
|
(5
|
)%
|
|||
|
Loss before income taxes
|
|
$
|
(40,154
|
)
|
|
$
|
(33,598
|
)
|
|
$
|
6,556
|
|
|
20
|
%
|
|
*
|
Less than 1%.
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||
|
|
Fair
value
|
|
Amortized Cost
|
|
Fair
value
|
|
Amortized Cost
|
|
U.S. government and agencies
|
*
|
|
*
|
|
*
|
|
*
|
|
Foreign government
|
6%
|
|
6%
|
|
6%
|
|
5%
|
|
States and political subdivisions
|
2%
|
|
2%
|
|
2%
|
|
2%
|
|
Corporate
|
67%
|
|
67%
|
|
68%
|
|
68%
|
|
Mortgage- and asset-backed securities
|
14%
|
|
14%
|
|
16%
|
|
16%
|
|
Equity securities
|
2%
|
|
2%
|
|
2%
|
|
2%
|
|
Trading securities
|
1%
|
|
1%
|
|
1%
|
|
1%
|
|
Cash and cash equivalents
|
8%
|
|
8%
|
|
5%
|
|
6%
|
|
Total
|
100%
|
|
100%
|
|
100%
|
|
100%
|
|
*
|
Less than 1%.
|
|
|
December 31,
|
||
|
|
2013
|
|
2012
|
|
Average rating of our fixed-maturity portfolio
|
A
|
|
A
|
|
Average duration of our fixed-maturity portfolio
|
4.0 years
|
|
3.9 years
|
|
Average book yield of our fixed-maturity portfolio
|
4.93%
|
|
5.32%
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||
|
|
Amortized cost
|
|
%
|
|
Amortized cost
|
|
%
|
||||
|
|
(Dollars in thousands)
|
||||||||||
|
AAA
|
$
|
296,717
|
|
|
18%
|
|
$
|
317,104
|
|
|
18%
|
|
AA
|
133,406
|
|
|
8%
|
|
132,021
|
|
|
8%
|
||
|
A
|
386,460
|
|
|
23%
|
|
403,029
|
|
|
24%
|
||
|
BBB
|
777,111
|
|
|
46%
|
|
777,719
|
|
|
45%
|
||
|
Below investment grade
|
80,835
|
|
|
5%
|
|
88,422
|
|
|
5%
|
||
|
Not rated
|
1,484
|
|
|
*
|
|
1,049
|
|
|
*
|
||
|
Total
|
$
|
1,676,013
|
|
|
100%
|
|
$
|
1,719,344
|
|
|
100%
|
|
*
|
Less than 1%.
|
|
|
December 31, 2013
|
||||||||||||
|
Issuer
|
Fair value
|
|
Cost or amortized cost
|
|
Unrealized
gain (loss)
|
|
Credit
rating
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
General Electric Co
|
$
|
26,661
|
|
|
$
|
23,628
|
|
|
$
|
3,033
|
|
|
AA-
|
|
Government of Canada
|
26,112
|
|
|
26,199
|
|
|
(87
|
)
|
|
AAA
|
|||
|
International Business Machines Corp
|
12,088
|
|
|
11,855
|
|
|
233
|
|
|
AA-
|
|||
|
Province of Ontario Canada
|
10,851
|
|
|
9,969
|
|
|
882
|
|
|
AA-
|
|||
|
Iberdrola SA
|
10,431
|
|
|
9,461
|
|
|
970
|
|
|
BBB
|
|||
|
National Rural Utilities Cooperative
|
9,901
|
|
|
7,468
|
|
|
2,433
|
|
|
A+
|
|||
|
Western Union Co
|
8,828
|
|
|
8,784
|
|
|
44
|
|
|
BBB+
|
|||
|
MetLife Inc
|
8,693
|
|
|
8,589
|
|
|
104
|
|
|
A-
|
|||
|
Province of Quebec Canada
|
7,912
|
|
|
7,218
|
|
|
694
|
|
|
A+
|
|||
|
Goldman Sachs Group Inc
|
7,854
|
|
|
7,357
|
|
|
497
|
|
|
A-
|
|||
|
Total – ten largest holdings
|
$
|
129,331
|
|
|
$
|
120,528
|
|
|
$
|
8,803
|
|
|
|
|
Total – fixed-maturity and equity securities
|
$
|
1,808,597
|
|
|
$
|
1,708,605
|
|
|
|
|
|
||
|
Percent of total fixed-maturity and equity securities
|
7
|
%
|
|
7
|
%
|
|
|
|
|
||||
|
|
December 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|||||||
|
Due from reinsurers
|
$
|
4,055,054
|
|
|
$
|
4,005,194
|
|
|
$
|
49,860
|
|
|
1
|
%
|
|
Deferred policy acquisition costs, net
|
1,208,466
|
|
|
1,066,422
|
|
|
142,044
|
|
|
13
|
%
|
|||
|
Liabilities:
|
|
|
|
|
|
|
|
|||||||
|
Future policy benefits
|
5,063,103
|
|
|
4,850,488
|
|
|
212,615
|
|
|
4
|
%
|
|||
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Net cash provided by operating activities
|
$
|
187,899
|
|
|
$
|
124,333
|
|
|
$
|
87,215
|
|
|
Net cash provided by investing activities
|
35,484
|
|
|
62,294
|
|
|
128,699
|
|
|||
|
Net cash used in financing activities
|
(184,940
|
)
|
|
(211,086
|
)
|
|
(206,556
|
)
|
|||
|
Effect of foreign exchange rate changes on cash
|
(1,470
|
)
|
|
597
|
|
|
682
|
|
|||
|
Change in cash and cash equivalents
|
$
|
36,973
|
|
|
$
|
(23,862
|
)
|
|
$
|
10,040
|
|
|
Agency
|
|
Senior debt rating
|
|
Moody’s
|
|
Baa2, stable outlook
|
|
Standard & Poor's
|
|
A-, stable outlook
|
|
A.M. Best Company
|
|
a-, stable outlook
|
|
Agency
|
|
Financial strength rating
|
|
Moody’s
|
|
A2, stable outlook
|
|
Standard & Poor's
|
|
AA-, stable outlook
|
|
A.M. Best Company
|
|
A+, stable outlook
|
|
|
December 31, 2013
|
||||||||||||||||||||||
|
|
Total
Liability
|
|
Total
Payments
|
|
Less than
1 year
|
|
1-3
years
|
|
3-5
years
|
|
More than
5 years
|
||||||||||||
|
|
(In millions)
|
||||||||||||||||||||||
|
Future policy benefits
|
$
|
5,063
|
|
|
$
|
16,763
|
|
|
$
|
1,131
|
|
|
$
|
2,224
|
|
|
$
|
2,115
|
|
|
$
|
11,293
|
|
|
Policy claims and other benefits payable
|
253
|
|
|
253
|
|
|
253
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Other policyholder funds
|
338
|
|
|
338
|
|
|
338
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Long-term debt principal
|
374
|
|
|
375
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
375
|
|
||||||
|
Interest obligations
|
8
|
|
|
207
|
|
|
25
|
|
|
47
|
|
|
48
|
|
|
87
|
|
||||||
|
Commissions
|
21
|
|
|
392
|
|
|
114
|
|
|
49
|
|
|
45
|
|
|
184
|
|
||||||
|
Purchase obligations
|
5
|
|
|
43
|
|
|
25
|
|
|
18
|
|
|
—
|
|
|
—
|
|
||||||
|
Operating lease obligations
|
n/a
|
|
|
82
|
|
|
7
|
|
|
13
|
|
|
12
|
|
|
50
|
|
||||||
|
Current income tax payable
|
15
|
|
|
15
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Other liabilities
|
344
|
|
|
334
|
|
|
310
|
|
|
24
|
|
|
—
|
|
|
—
|
|
||||||
|
Total contractual obligations
|
$
|
6,421
|
|
|
$
|
18,802
|
|
|
$
|
2,218
|
|
|
$
|
2,375
|
|
|
$
|
2,220
|
|
|
$
|
11,989
|
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Assets
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Fixed-maturity securities available for sale, at fair value (amortized cost: $1,663,022 in 2013 and $1,711,582 in 2012)
|
$
|
1,755,712
|
|
|
$
|
1,887,014
|
|
|
Equity securities available for sale, at fair value (cost: $32,592 in 2013 and $29,955 in 2012)
|
39,894
|
|
|
37,147
|
|
||
|
Trading securities, at fair value (cost: $13,025 in 2013 and $7,740 in 2012)
|
12,991
|
|
|
7,762
|
|
||
|
Policy loans
|
26,806
|
|
|
24,613
|
|
||
|
Total investments
|
1,835,403
|
|
|
1,956,536
|
|
||
|
Cash and cash equivalents
|
149,189
|
|
|
112,216
|
|
||
|
Accrued investment income
|
18,127
|
|
|
19,540
|
|
||
|
Due from reinsurers
|
4,055,054
|
|
|
4,005,194
|
|
||
|
Deferred policy acquisition costs, net
|
1,208,466
|
|
|
1,066,422
|
|
||
|
Premiums and other receivables
|
175,789
|
|
|
170,656
|
|
||
|
Intangible assets, net
|
68,863
|
|
|
69,816
|
|
||
|
Deferred income taxes
|
32,450
|
|
|
17,256
|
|
||
|
Other assets
|
282,780
|
|
|
302,126
|
|
||
|
Separate account assets
|
2,503,829
|
|
|
2,618,115
|
|
||
|
Total assets
|
$
|
10,329,950
|
|
|
$
|
10,337,877
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Future policy benefits
|
$
|
5,063,103
|
|
|
$
|
4,850,488
|
|
|
Unearned premiums
|
1,802
|
|
|
6,056
|
|
||
|
Policy claims and other benefits payable
|
253,304
|
|
|
254,533
|
|
||
|
Other policyholders’ funds
|
337,977
|
|
|
345,721
|
|
||
|
Notes payable
|
374,481
|
|
|
374,433
|
|
||
|
Current income tax payable
|
15,019
|
|
|
28,407
|
|
||
|
Deferred income taxes
|
90,866
|
|
|
86,204
|
|
||
|
Other liabilities
|
377,690
|
|
|
358,577
|
|
||
|
Payable under securities lending
|
89,852
|
|
|
139,927
|
|
||
|
Separate account liabilities
|
2,503,829
|
|
|
2,618,115
|
|
||
|
Commitments and contingent liabilities
(see Commitments and Contingent Liabilities note)
|
|
|
|
|
|
||
|
Total liabilities
|
9,107,923
|
|
|
9,062,461
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Common stock ($.01 par value; authorized 500,000 in 2013 and 2012; and issued 54,834 shares in 2013 and 56,374 shares in 2012)
|
548
|
|
|
564
|
|
||
|
Paid-in capital
|
472,633
|
|
|
602,269
|
|
||
|
Retained earnings
|
640,840
|
|
|
503,173
|
|
||
|
Accumulated other comprehensive income, net of income tax:
|
|
|
|
||||
|
Unrealized foreign currency translation gains (losses)
|
41,974
|
|
|
55,487
|
|
||
|
Net unrealized investment gains (losses):
|
|
|
|
||||
|
Net unrealized investment gains not other-than-temporarily impaired
|
67,379
|
|
|
114,958
|
|
||
|
Net unrealized investment losses other-than-temporarily impaired
|
(1,347
|
)
|
|
(1,035
|
)
|
||
|
Total stockholders’ equity
|
1,222,027
|
|
|
1,275,416
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
10,329,950
|
|
|
$
|
10,337,877
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Direct premiums
|
$
|
2,302,069
|
|
|
$
|
2,267,975
|
|
|
$
|
2,229,467
|
|
|
Ceded premiums
|
(1,644,158
|
)
|
|
(1,663,753
|
)
|
|
(1,703,075
|
)
|
|||
|
Net premiums
|
657,911
|
|
|
604,222
|
|
|
526,392
|
|
|||
|
Commissions and fees
|
471,808
|
|
|
429,044
|
|
|
414,471
|
|
|||
|
Net investment income
|
88,752
|
|
|
100,804
|
|
|
108,601
|
|
|||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
6,246
|
|
|
11,382
|
|
|
6,440
|
|
|||
|
Other, net
|
42,731
|
|
|
45,263
|
|
|
47,189
|
|
|||
|
Total revenues
|
1,267,448
|
|
|
1,190,715
|
|
|
1,103,093
|
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
||||||
|
Benefits and claims
|
301,475
|
|
|
278,747
|
|
|
242,696
|
|
|||
|
Amortization of deferred policy acquisition costs
|
129,183
|
|
|
118,598
|
|
|
104,034
|
|
|||
|
Sales commissions
|
232,237
|
|
|
204,569
|
|
|
191,722
|
|
|||
|
Insurance expenses
|
108,658
|
|
|
96,541
|
|
|
89,192
|
|
|||
|
Insurance commissions
|
22,471
|
|
|
27,555
|
|
|
38,618
|
|
|||
|
Interest expense
|
35,018
|
|
|
33,101
|
|
|
27,968
|
|
|||
|
Other operating expenses
|
187,208
|
|
|
164,716
|
|
|
164,954
|
|
|||
|
Total benefits and expenses
|
1,016,250
|
|
|
923,827
|
|
|
859,184
|
|
|||
|
Income before income taxes
|
251,198
|
|
|
266,888
|
|
|
243,909
|
|
|||
|
Income taxes
|
88,473
|
|
|
93,082
|
|
|
86,718
|
|
|||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
2.87
|
|
|
$
|
2.77
|
|
|
$
|
2.11
|
|
|
Diluted
|
$
|
2.83
|
|
|
$
|
2.71
|
|
|
$
|
2.08
|
|
|
Weighted-average shares used in computing earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
55,834
|
|
|
61,059
|
|
|
72,283
|
|
|||
|
Diluted
|
56,625
|
|
|
62,401
|
|
|
73,107
|
|
|||
|
Supplemental disclosures:
|
|
|
|
|
|
||||||
|
Total impairment losses
|
$
|
(1,095
|
)
|
|
$
|
(1,204
|
)
|
|
$
|
(2,198
|
)
|
|
Impairment losses recognized in other comprehensive income before income taxes
|
479
|
|
|
563
|
|
|
183
|
|
|||
|
Net impairment losses recognized in earnings
|
(616
|
)
|
|
(641
|
)
|
|
(2,015
|
)
|
|||
|
Other net realized investment gains (losses)
|
6,862
|
|
|
12,023
|
|
|
8,455
|
|
|||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
$
|
6,246
|
|
|
$
|
11,382
|
|
|
$
|
6,440
|
|
|
Dividends declared per share
|
$
|
0.44
|
|
|
$
|
0.24
|
|
|
$
|
0.10
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Other comprehensive income (loss) before income taxes:
|
|
|
|
|
|
||||||
|
Unrealized investment gains (losses):
|
|
|
|
|
|
||||||
|
Change in unrealized holding gains (losses) on investment securities
|
(68,769
|
)
|
|
39,945
|
|
|
3,839
|
|
|||
|
Reclassification adjustment for realized investment (gains) losses included in net income
|
(4,909
|
)
|
|
(11,475
|
)
|
|
(5,926
|
)
|
|||
|
Foreign currency translation adjustments:
|
|
|
|
|
|
||||||
|
Change in unrealized foreign currency translation gains (losses)
|
(13,695
|
)
|
|
4,221
|
|
|
(3,645
|
)
|
|||
|
Total other comprehensive income (loss) before income taxes
|
(87,373
|
)
|
|
32,691
|
|
|
(5,732
|
)
|
|||
|
Income tax expense (benefit) related to items of other comprehensive income (loss)
|
(25,969
|
)
|
|
9,946
|
|
|
(1,457
|
)
|
|||
|
Other comprehensive income (loss), net of income taxes
|
(61,404
|
)
|
|
22,745
|
|
|
(4,275
|
)
|
|||
|
Total comprehensive income
|
$
|
101,321
|
|
|
$
|
196,551
|
|
|
$
|
152,916
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||
|
Common stock:
|
|
|
|
|
|
||||||
|
Balance, beginning of period
|
$
|
564
|
|
|
$
|
649
|
|
|
$
|
728
|
|
|
Repurchases of shares
|
(29
|
)
|
|
(99
|
)
|
|
(180
|
)
|
|||
|
Net issuance of common stock
|
13
|
|
|
14
|
|
|
101
|
|
|||
|
Balance, end of period
|
548
|
|
|
564
|
|
|
649
|
|
|||
|
Paid-in capital:
|
|
|
|
|
|
||||||
|
Balance, beginning of period
|
602,269
|
|
|
835,232
|
|
|
1,010,635
|
|
|||
|
Share-based compensation
|
39,195
|
|
|
33,236
|
|
|
29,444
|
|
|||
|
Net issuance of common stock
|
(13
|
)
|
|
(14
|
)
|
|
(101
|
)
|
|||
|
Repurchases of common stock
|
(101,044
|
)
|
|
(268,113
|
)
|
|
(203,929
|
)
|
|||
|
Repurchases of warrants
|
(68,399
|
)
|
|
—
|
|
|
—
|
|
|||
|
Adjustments to paid-in capital, other
|
625
|
|
|
1,928
|
|
|
(817
|
)
|
|||
|
Balance, end of period
|
472,633
|
|
|
602,269
|
|
|
835,232
|
|
|||
|
Retained earnings:
|
|
|
|
|
|
||||||
|
Balance, beginning of period
|
503,173
|
|
|
344,104
|
|
|
194,225
|
|
|||
|
Net income
|
162,725
|
|
|
173,806
|
|
|
157,191
|
|
|||
|
Dividends
|
(25,058
|
)
|
|
(14,737
|
)
|
|
(7,312
|
)
|
|||
|
Balance, end of period
|
640,840
|
|
|
503,173
|
|
|
344,104
|
|
|||
|
Accumulated other comprehensive income:
|
|
|
|
|
|
||||||
|
Balance, beginning of period
|
169,410
|
|
|
146,665
|
|
|
150,940
|
|
|||
|
Change in foreign currency translation adjustment, net of income tax expense (benefit) of $(182) in 2013, $(18) in 2012, and $0 in 2011
|
(13,513
|
)
|
|
4,239
|
|
|
(3,645
|
)
|
|||
|
Change in net unrealized investment gains (losses) during the period, net of income taxes:
|
|
|
|
|
|
||||||
|
Change in net unrealized investment gains (losses) not-other-than temporarily impaired, net of income tax expense (benefit) of $(25,619) in 2013, $9,624 in 2012, and $(1,785) in 2011
|
(47,579
|
)
|
|
17,876
|
|
|
(1,240
|
)
|
|||
|
Change in net unrealized investment gains (losses) other-than-temporarily impaired, net of income tax expense (benefit) of $(168) in 2013, $340 in 2012, and $328 in 2011
|
(312
|
)
|
|
630
|
|
|
610
|
|
|||
|
Balance, end of period
|
108,006
|
|
|
169,410
|
|
|
146,665
|
|
|||
|
Total stockholders’ equity
|
$
|
1,222,027
|
|
|
$
|
1,275,416
|
|
|
$
|
1,326,650
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Adjustments to reconcile net income to cash provided by (used in) operating activities:
|
|
|
|
|
|
||||||
|
Change in future policy benefits and other policy liabilities
|
228,341
|
|
|
243,062
|
|
|
213,583
|
|
|||
|
Deferral of policy acquisition costs
|
(267,523
|
)
|
|
(268,154
|
)
|
|
(263,603
|
)
|
|||
|
Amortization of deferred policy acquisition costs
|
129,183
|
|
|
118,598
|
|
|
104,034
|
|
|||
|
Deferred tax provision
|
18,333
|
|
|
13,332
|
|
|
(3,424
|
)
|
|||
|
Change in income taxes
|
(13,045
|
)
|
|
(12,707
|
)
|
|
(16,733
|
)
|
|||
|
Realized investment (gains) losses, including other-than-temporary impairments
|
(6,246
|
)
|
|
(11,382
|
)
|
|
(6,440
|
)
|
|||
|
Accretion and amortization of investments
|
(4,554
|
)
|
|
(2,766
|
)
|
|
(2,818
|
)
|
|||
|
Depreciation and amortization
|
10,803
|
|
|
10,095
|
|
|
10,731
|
|
|||
|
Change in due from reinsurers
|
(73,070
|
)
|
|
(141,918
|
)
|
|
(132,411
|
)
|
|||
|
Change in premiums and other receivables
|
(8,241
|
)
|
|
(762
|
)
|
|
3,464
|
|
|||
|
Trading securities sold, matured, or called (acquired), net
|
(5,265
|
)
|
|
35,738
|
|
|
3,597
|
|
|||
|
Share-based compensation
|
13,788
|
|
|
18,944
|
|
|
17,886
|
|
|||
|
Change in other operating assets and liabilities, net
|
2,670
|
|
|
(51,553
|
)
|
|
2,158
|
|
|||
|
Net cash provided by (used in) operating activities
|
187,899
|
|
|
124,333
|
|
|
87,215
|
|
|||
|
Cash flows from investing activities:
|
|
|
|
|
|
||||||
|
Available-for-sale investments sold, matured or called:
|
|
|
|
|
|
||||||
|
Fixed-maturity securities — sold
|
98,277
|
|
|
304,838
|
|
|
214,807
|
|
|||
|
Fixed-maturity securities — matured or called
|
266,738
|
|
|
263,351
|
|
|
375,124
|
|
|||
|
Equity securities
|
6,200
|
|
|
2,828
|
|
|
3,037
|
|
|||
|
Available-for-sale investments acquired:
|
|
|
|
|
|
||||||
|
Fixed-maturity securities
|
(308,904
|
)
|
|
(492,094
|
)
|
|
(460,459
|
)
|
|||
|
Equity securities
|
(3,009
|
)
|
|
(5,680
|
)
|
|
(144
|
)
|
|||
|
Purchases of property and equipment and other investing activities, net
|
(23,818
|
)
|
|
(10,949
|
)
|
|
(3,666
|
)
|
|||
|
Cash collateral received (returned) on loaned securities, net
|
(50,075
|
)
|
|
(9,431
|
)
|
|
(32,368
|
)
|
|||
|
Sales (purchases) of short-term investments using securities lending collateral, net
|
50,075
|
|
|
9,431
|
|
|
32,368
|
|
|||
|
Net cash provided by (used in) investing activities
|
35,484
|
|
|
62,294
|
|
|
128,699
|
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|
||||||
|
Dividends paid
|
(25,058
|
)
|
|
(14,737
|
)
|
|
(7,312
|
)
|
|||
|
Common stock repurchased
|
(101,073
|
)
|
|
(268,212
|
)
|
|
(204,109
|
)
|
|||
|
Warrants repurchased
|
(68,399
|
)
|
|
—
|
|
|
—
|
|
|||
|
Excess tax benefits on share-based compensation
|
9,590
|
|
|
5,266
|
|
|
4,865
|
|
|||
|
Proceeds from issuance of Senior Notes, net of discount
|
—
|
|
|
374,411
|
|
|
—
|
|
|||
|
Payment of note issued to Citigroup
|
—
|
|
|
(300,000
|
)
|
|
—
|
|
|||
|
Payments of deferred financing costs
|
—
|
|
|
(7,814
|
)
|
|
—
|
|
|||
|
Net cash provided by (used in) financing activities
|
(184,940
|
)
|
|
(211,086
|
)
|
|
(206,556
|
)
|
|||
|
Effect of foreign exchange rate changes on cash
|
(1,470
|
)
|
|
597
|
|
|
682
|
|
|||
|
Change in cash and cash equivalents
|
36,973
|
|
|
(23,862
|
)
|
|
10,040
|
|
|||
|
Cash and cash equivalents, beginning of period
|
112,216
|
|
|
136,078
|
|
|
126,038
|
|
|||
|
Cash and cash equivalents, end of period
|
$
|
149,189
|
|
|
$
|
112,216
|
|
|
$
|
136,078
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
||||||
|
Income taxes paid
|
$
|
68,599
|
|
|
$
|
85,365
|
|
|
$
|
96,305
|
|
|
Interest paid
|
32,905
|
|
|
38,416
|
|
|
27,555
|
|
|||
|
Impairment losses included in realized investment gains (losses), including other-than-temporary impairments
|
616
|
|
|
641
|
|
|
2,015
|
|
|||
|
Non-cash activities:
|
|
|
|
|
|
||||||
|
Share-based compensation
|
$
|
39,195
|
|
|
$
|
33,236
|
|
|
$
|
29,444
|
|
|
Net contributions from (distributions to) Citigroup
|
—
|
|
|
1,961
|
|
|
1,426
|
|
|||
|
(1)
|
Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies
|
|
•
|
Available-for-sale fixed-maturity securities, including bonds and redeemable preferred stocks not classified as trading securities, are carried at fair value. When quoted market values are unavailable, we obtain estimates from independent pricing services or estimate fair value based upon a comparison to quoted issues of the same issuer or of other issuers with similar characteristics.
|
|
•
|
Equity securities, including common and nonredeemable preferred stocks, are classified as available for sale and are carried at fair value. When quoted market values are unavailable, we obtain estimates from independent pricing services or estimates fair value based upon a comparison to quoted issues of the same issuer or of other issuers with similar characteristics.
|
|
•
|
Trading securities, which primarily consist of bonds, are carried at fair value. Changes in fair value of trading securities are included in net investment income in the period in which the change occurred.
|
|
•
|
Policy loans are carried at unpaid principal balances, which approximate fair value.
|
|
|
December 31,
|
||||||||||||||||||||||
|
|
2013
|
|
2012
|
||||||||||||||||||||
|
|
Gross carrying amount
|
|
Accumulated amortization
|
|
Net carrying amount
|
|
Gross carrying amount
|
|
Accumulated amortization
|
|
Net carrying amount
|
||||||||||||
|
|
(In thousands)
|
||||||||||||||||||||||
|
Indefinite-lived intangible asset
|
$
|
45,275
|
|
|
n/a
|
|
|
$
|
45,275
|
|
|
$
|
45,275
|
|
|
n/a
|
|
|
$
|
45,275
|
|
||
|
Amortizing intangible assets
|
88,719
|
|
|
(65,131
|
)
|
|
23,588
|
|
|
86,162
|
|
|
(61,621
|
)
|
|
24,541
|
|
||||||
|
Total intangible assets
|
$
|
133,994
|
|
|
$
|
(65,131
|
)
|
|
$
|
68,863
|
|
|
$
|
131,437
|
|
|
$
|
(61,621
|
)
|
|
$
|
69,816
|
|
|
|
Estimated Useful Life
|
|
Data processing equipment and software
|
3 to 5 years
|
|
Leasehold improvements
|
Lesser of 15 years or remaining life of lease
|
|
Furniture and other equipment
|
5 to 15 years
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Data processing equipment and software
|
$
|
59,237
|
|
|
$
|
56,872
|
|
|
Leasehold improvements
|
19,090
|
|
|
14,201
|
|
||
|
Other, principally furniture and equipment
|
34,783
|
|
|
24,933
|
|
||
|
|
113,110
|
|
|
96,006
|
|
||
|
Accumulated depreciation
|
(88,060
|
)
|
|
(82,648
|
)
|
||
|
Net property and equipment
|
$
|
25,050
|
|
|
$
|
13,358
|
|
|
|
December 31,
|
||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||||
|
|
(In thousands)
|
||||||||||||
|
Assets:
|
|
|
|
|
|
||||||||
|
Term life insurance segment
|
$
|
6,783,194
|
|
|
$
|
6,400,126
|
|
|
$
|
5,949,187
|
|
||
|
Investment and savings products segment
|
2,699,000
|
|
|
2,810,137
|
|
|
2,591,137
|
|
|||||
|
Corporate and other distributed products segment
|
847,756
|
|
|
1,127,614
|
|
|
1,311,496
|
|
|||||
|
Total assets
|
$
|
10,329,950
|
|
|
$
|
10,337,877
|
|
|
$
|
9,851,820
|
|
||
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Term life insurance segment
|
$
|
694,975
|
|
|
$
|
640,134
|
|
|
$
|
552,975
|
|
|
Investment and savings products segment
|
457,138
|
|
|
413,965
|
|
|
396,703
|
|
|||
|
Corporate and other distributed products segment
|
115,335
|
|
|
136,616
|
|
|
153,415
|
|
|||
|
Total revenues
|
$
|
1,267,448
|
|
|
$
|
1,190,715
|
|
|
$
|
1,103,093
|
|
|
Income (loss) before income taxes:
|
|
|
|
|
|
||||||
|
Term life insurance segment
|
$
|
197,201
|
|
|
$
|
185,926
|
|
|
$
|
160,431
|
|
|
Investment and savings products segment
|
105,149
|
|
|
121,116
|
|
|
117,076
|
|
|||
|
Corporate and other distributed products segment
|
(51,152
|
)
|
|
(40,154
|
)
|
|
(33,598
|
)
|
|||
|
Total income before income taxes
|
$
|
251,198
|
|
|
$
|
266,888
|
|
|
$
|
243,909
|
|
|
|
December 31,
|
||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||||
|
|
(In thousands)
|
||||||||||||
|
Long-lived assets by country:
|
|
|
|
|
|
||||||||
|
United States
|
$
|
93,276
|
|
|
$
|
82,724
|
|
|
$
|
84,550
|
|
||
|
Canada
|
637
|
|
|
450
|
|
|
316
|
|
|||||
|
Total long-lived assets
|
$
|
93,913
|
|
|
$
|
83,174
|
|
|
$
|
84,866
|
|
||
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Revenues by country:
|
|
|
|
|
|
||||||
|
United States
|
$
|
1,035,064
|
|
|
$
|
971,615
|
|
|
$
|
895,067
|
|
|
Canada
|
232,384
|
|
|
219,100
|
|
|
208,026
|
|
|||
|
Total revenues
|
$
|
1,267,448
|
|
|
$
|
1,190,715
|
|
|
$
|
1,103,093
|
|
|
Income before income taxes by country:
|
|
|
|
|
|
||||||
|
United States
|
$
|
183,504
|
|
|
$
|
202,391
|
|
|
$
|
181,151
|
|
|
Canada
|
67,694
|
|
|
64,497
|
|
|
62,758
|
|
|||
|
Total income before income taxes
|
$
|
251,198
|
|
|
$
|
266,888
|
|
|
$
|
243,909
|
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Cost or
amortized
cost
|
|
Gross
unrealized
gains
|
|
Gross
unrealized
losses
|
|
Fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Securities available for sale, carried at fair value:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
8,696
|
|
|
$
|
485
|
|
|
$
|
(127
|
)
|
|
$
|
9,054
|
|
|
Foreign government
|
111,610
|
|
|
7,512
|
|
|
(2,766
|
)
|
|
116,356
|
|
||||
|
States and political subdivisions
|
32,308
|
|
|
1,860
|
|
|
(468
|
)
|
|
33,700
|
|
||||
|
Corporates
|
1,240,100
|
|
|
84,545
|
|
|
(11,931
|
)
|
|
1,312,714
|
|
||||
|
Mortgage- and asset-backed securities
|
270,308
|
|
|
14,610
|
|
|
(1,030
|
)
|
|
283,888
|
|
||||
|
Total fixed-maturity securities
(1)
|
1,663,022
|
|
|
109,012
|
|
|
(16,322
|
)
|
|
1,755,712
|
|
||||
|
Equity securities
|
32,592
|
|
|
7,935
|
|
|
(633
|
)
|
|
39,894
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
1,695,614
|
|
|
$
|
116,947
|
|
|
$
|
(16,955
|
)
|
|
$
|
1,795,606
|
|
|
(1)
|
Includes
$2.1 million
of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income.
|
|
|
December 31, 2012
|
||||||||||||||
|
|
Cost or
amortized
cost
|
|
Gross
unrealized
gains
|
|
Gross
unrealized
losses
|
|
Fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Securities available for sale, carried at fair value:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
6,722
|
|
|
$
|
812
|
|
|
$
|
—
|
|
|
$
|
7,534
|
|
|
Foreign government
|
101,171
|
|
|
16,238
|
|
|
(17
|
)
|
|
117,392
|
|
||||
|
States and political subdivisions
|
31,176
|
|
|
3,596
|
|
|
(19
|
)
|
|
34,753
|
|
||||
|
Corporates
|
1,265,179
|
|
|
134,710
|
|
|
(2,763
|
)
|
|
1,397,126
|
|
||||
|
Mortgage- and asset-backed securities
|
307,334
|
|
|
23,999
|
|
|
(1,124
|
)
|
|
330,209
|
|
||||
|
Total fixed-maturity securities
(1)
|
1,711,582
|
|
|
179,355
|
|
|
(3,923
|
)
|
|
1,887,014
|
|
||||
|
Equity securities
|
29,955
|
|
|
7,529
|
|
|
(337
|
)
|
|
37,147
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
1,741,537
|
|
|
$
|
186,884
|
|
|
$
|
(4,260
|
)
|
|
$
|
1,924,161
|
|
|
(1)
|
Includes
$1.6 million
of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income.
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Net unrealized investment gains (losses) including foreign currency translation adjustment and other-than-temporary impairments:
|
|
|
|
||||
|
Fixed-maturity and equity securities
|
$
|
99,992
|
|
|
$
|
182,624
|
|
|
Currency swaps
|
72
|
|
|
97
|
|
||
|
Foreign currency translation adjustment
|
1,523
|
|
|
(7,456
|
)
|
||
|
Other-than-temporary impairments
|
2,072
|
|
|
1,592
|
|
||
|
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments
|
103,659
|
|
|
176,857
|
|
||
|
Deferred income taxes
|
(36,280
|
)
|
|
(61,899
|
)
|
||
|
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments, net of tax
|
$
|
67,379
|
|
|
$
|
114,958
|
|
|
|
December 31, 2013
|
||||||
|
|
Amortized cost
|
|
Fair value
|
||||
|
|
(In thousands)
|
||||||
|
Due in one year or less
|
$
|
167,818
|
|
|
$
|
170,905
|
|
|
Due after one year through five years
|
482,656
|
|
|
522,966
|
|
||
|
Due after five years through 10 years
|
697,908
|
|
|
730,409
|
|
||
|
Due after 10 years
|
44,332
|
|
|
47,544
|
|
||
|
|
1,392,714
|
|
|
1,471,824
|
|
||
|
Mortgage- and asset-backed securities
|
270,308
|
|
|
283,888
|
|
||
|
Total fixed-maturity securities
|
$
|
1,663,022
|
|
|
$
|
1,755,712
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Fixed-maturity securities
|
$
|
89,860
|
|
|
$
|
100,520
|
|
|
$
|
109,907
|
|
|
Equity securities
|
1,186
|
|
|
1,051
|
|
|
717
|
|
|||
|
Policy loans and other invested assets
|
1,363
|
|
|
1,251
|
|
|
1,414
|
|
|||
|
Cash and cash equivalents
|
272
|
|
|
454
|
|
|
307
|
|
|||
|
Market return on deposit asset underlying 10% Coinsurance agreement
|
938
|
|
|
2,903
|
|
|
2,020
|
|
|||
|
Gross investment income
|
93,619
|
|
|
106,179
|
|
|
114,365
|
|
|||
|
Investment expenses
|
(4,867
|
)
|
|
(5,375
|
)
|
|
(5,764
|
)
|
|||
|
Net investment income
|
$
|
88,752
|
|
|
$
|
100,804
|
|
|
$
|
108,601
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Gross realized investment gains (losses):
|
|
|
|
|
|
||||||
|
Gross gains from sales
|
$
|
6,734
|
|
|
$
|
11,882
|
|
|
$
|
8,382
|
|
|
Gross losses from sales
|
(1,209
|
)
|
|
(83
|
)
|
|
(441
|
)
|
|||
|
Gross gains from securities transferred from available-for-sale to trading
|
—
|
|
|
323
|
|
|
—
|
|
|||
|
Gross losses from securities transferred from available-for-sale to trading
|
—
|
|
|
(6
|
)
|
|
—
|
|
|||
|
Other-than-temporary impairment losses
|
(616
|
)
|
|
(641
|
)
|
|
(2,015
|
)
|
|||
|
Gains (losses) from bifurcated options
|
1,337
|
|
|
(93
|
)
|
|
514
|
|
|||
|
Net realized investment gains (losses)
|
$
|
6,246
|
|
|
$
|
11,382
|
|
|
$
|
6,440
|
|
|
Supplemental Information:
|
|
|
|
|
|
||||||
|
Realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings for unrealized gains (losses) realized upon the sale of available-for-sale securities
|
$
|
4,909
|
|
|
$
|
11,475
|
|
|
$
|
5,926
|
|
|
Tax expense (benefit) associated with realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings for unrealized gains (losses) realized upon the sale of available-for-sale securities
|
$
|
1,718
|
|
|
$
|
4,016
|
|
|
$
|
2,074
|
|
|
Proceeds from sales or other redemptions
|
$
|
371,215
|
|
|
$
|
571,017
|
|
|
$
|
592,968
|
|
|
•
|
Analysis of individual investments that have fair values less than a pre-defined percentage of amortized cost, including consideration of the length of time the investment has been in an unrealized loss position;
|
|
•
|
Analysis of corporate fixed-maturity securities by reviewing the issuer’s most recent performance to date, including analyst reviews, analyst outlooks and rating agency information;
|
|
•
|
Analysis of commercial mortgage-backed securities based on an assessment of performance to date, credit enhancement, risk analytics and outlook, underlying collateral, loss projections, rating agency information and available third-party reviews and analytics;
|
|
•
|
Analysis of residential mortgage-backed securities based on loss projections provided by models compared to current credit enhancement levels;
|
|
•
|
Analysis of our other fixed-maturity and equity security investments, as required based on the type of investment; and
|
|
•
|
Analysis of downward credit migrations that occurred during the quarter.
|
|
|
December 31, 2013
|
||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
||||||||||
|
|
(Dollars in thousands)
|
||||||||||||||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. government and agencies
|
$
|
3,817
|
|
|
$
|
(36
|
)
|
|
3
|
|
|
$
|
859
|
|
|
$
|
(91
|
)
|
|
2
|
|
|
Foreign government
|
34,869
|
|
|
(2,190
|
)
|
|
47
|
|
|
5,999
|
|
|
(576
|
)
|
|
13
|
|
||||
|
States and political subdivisions
|
8,520
|
|
|
(468
|
)
|
|
11
|
|
|
152
|
|
|
—
|
|
(1)
|
1
|
|
||||
|
Corporates
|
296,192
|
|
|
(9,510
|
)
|
|
295
|
|
|
19,022
|
|
|
(2,421
|
)
|
|
31
|
|
||||
|
Mortgage- and asset-backed securities
|
54,215
|
|
|
(536
|
)
|
|
46
|
|
|
10,523
|
|
|
(494
|
)
|
|
9
|
|
||||
|
Total fixed-maturity securities
|
397,613
|
|
|
(12,740
|
)
|
|
|
|
36,555
|
|
|
(3,582
|
)
|
|
|
||||||
|
Equity securities
|
3,081
|
|
|
(633
|
)
|
|
7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
400,694
|
|
|
$
|
(13,373
|
)
|
|
|
|
$
|
36,555
|
|
|
$
|
(3,582
|
)
|
|
|
||
|
(1)
|
Less than $1 thousand.
|
|
|
December 31, 2012
|
||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
||||||||||
|
|
(Dollars in thousands)
|
||||||||||||||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Foreign government
|
$
|
5,146
|
|
|
$
|
(17
|
)
|
|
12
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
States and political subdivisions
|
1,498
|
|
|
(19
|
)
|
|
3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Corporates
|
70,176
|
|
|
(1,189
|
)
|
|
58
|
|
|
7,055
|
|
|
(1,574
|
)
|
|
11
|
|
||||
|
Mortgage- and asset-backed securities
|
15,367
|
|
|
(22
|
)
|
|
18
|
|
|
6,409
|
|
|
(1,102
|
)
|
|
10
|
|
||||
|
Total fixed-maturity securities
|
92,187
|
|
|
(1,247
|
)
|
|
|
|
13,464
|
|
|
(2,676
|
)
|
|
|
||||||
|
Equity securities
|
1,461
|
|
|
(147
|
)
|
|
6
|
|
|
522
|
|
|
(190
|
)
|
|
1
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
93,648
|
|
|
$
|
(1,394
|
)
|
|
|
|
$
|
13,986
|
|
|
$
|
(2,866
|
)
|
|
|
||
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
|
Amortized
cost
|
|
Fair
value
|
|
Amortized
cost
|
|
Fair
value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fixed-maturity securities in default
|
$
|
31
|
|
|
$
|
267
|
|
|
$
|
165
|
|
|
$
|
712
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Impairments on fixed-maturity securities not in default
|
$
|
609
|
|
|
$
|
479
|
|
|
$
|
1,831
|
|
|
Impairments on fixed-maturity securities in default
|
—
|
|
|
—
|
|
|
179
|
|
|||
|
Impairments on equity securities
|
7
|
|
|
162
|
|
|
5
|
|
|||
|
Total impairment charges
|
$
|
616
|
|
|
$
|
641
|
|
|
$
|
2,015
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Impairment losses related to securities which the Company does not intend to sell or is more-likely-than-not that it will not be required to sell:
|
|
|
|
|
|
||||||
|
Total OTTI losses recognized
|
$
|
832
|
|
|
$
|
991
|
|
|
$
|
1,109
|
|
|
Less portion of OTTI loss recognized in accumulated other comprehensive income (loss)
|
(479
|
)
|
|
(563
|
)
|
|
(183
|
)
|
|||
|
Net impairment losses recognized in earnings for securities that the Company does not intend to sell or is more-likely-than-not that it will not be required to sell before recovery
|
353
|
|
|
428
|
|
|
926
|
|
|||
|
OTTI losses recognized in earnings for securities that the Company intends to sell or more-likely-than-not will be required to sell before recovery
|
263
|
|
|
213
|
|
|
1,089
|
|
|||
|
Net impairment losses recognized in earnings
|
$
|
616
|
|
|
$
|
641
|
|
|
$
|
2,015
|
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Cumulative OTTI credit losses recognized for securities still held, beginning of period
|
$
|
14,171
|
|
|
$
|
17,403
|
|
|
Additions for OTTI securities where no credit losses were recognized prior to the beginning of the period
|
606
|
|
|
10
|
|
||
|
Additions for OTTI securities where credit losses have been recognized prior to the beginning of the period
|
3
|
|
|
469
|
|
||
|
Reductions due to sales, maturities or calls of credit impaired securities
|
(264
|
)
|
|
(3,711
|
)
|
||
|
Cumulative OTTI credit losses recognized for securities still held, end of period
|
$
|
14,516
|
|
|
$
|
14,171
|
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Aggregate notional balance of currency swaps
|
$
|
1,000
|
|
|
$
|
5,878
|
|
|
Aggregate fair value of currency swaps
|
(88
|
)
|
|
(2,048
|
)
|
||
|
•
|
Level 1. Quoted prices for identical instruments in active markets
. Level 1 primarily consists of financial instruments whose value is based on quoted market prices in active markets, such as exchange-traded common stocks and actively traded mutual fund investments;
|
|
•
|
Level 2. Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets
. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. Various inputs are considered in deriving the fair value of the underlying financial instrument, including interest rate, credit spread, and foreign exchange rates. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed-maturity and equity securities; government or agency securities; certain mortgage- and asset-backed securities and certain non-exchange-traded derivatives, such as currency swaps; and
|
|
•
|
Level 3. Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable
. Level 3 consists of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and models using significant inputs not based on, nor corroborated by, readily available market information. Valuations for this category primarily consist of non-binding broker quotes. Financial instruments in this category primarily include less liquid fixed-maturity corporate securities, mortgage- and asset-backed securities.
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fair value assets:
|
|
|
|
|
|
|
|
||||||||
|
Available-for-sale fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
—
|
|
|
$
|
9,054
|
|
|
$
|
—
|
|
|
$
|
9,054
|
|
|
Foreign government
|
—
|
|
|
116,356
|
|
|
—
|
|
|
116,356
|
|
||||
|
States and political subdivisions
|
—
|
|
|
33,700
|
|
|
—
|
|
|
33,700
|
|
||||
|
Corporates
|
1,282
|
|
|
1,310,739
|
|
|
693
|
|
|
1,312,714
|
|
||||
|
Mortgage- and asset-backed securities
|
—
|
|
|
282,341
|
|
|
1,547
|
|
|
283,888
|
|
||||
|
Total available-for-sale fixed-maturity securities
|
1,282
|
|
|
1,752,190
|
|
|
2,240
|
|
|
1,755,712
|
|
||||
|
Available-for-sale equity securities
|
34,868
|
|
|
4,978
|
|
|
48
|
|
|
39,894
|
|
||||
|
Trading securities
|
—
|
|
|
12,991
|
|
|
—
|
|
|
12,991
|
|
||||
|
Separate accounts
|
—
|
|
|
2,503,829
|
|
|
—
|
|
|
2,503,829
|
|
||||
|
Total fair value assets
|
$
|
36,150
|
|
|
$
|
4,273,988
|
|
|
$
|
2,288
|
|
|
$
|
4,312,426
|
|
|
Fair value liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Currency swaps
|
$
|
—
|
|
|
$
|
88
|
|
|
$
|
—
|
|
|
$
|
88
|
|
|
Separate accounts
|
—
|
|
|
2,503,829
|
|
|
—
|
|
|
2,503,829
|
|
||||
|
Total fair value liabilities
|
$
|
—
|
|
|
$
|
2,503,917
|
|
|
$
|
—
|
|
|
$
|
2,503,917
|
|
|
|
December 31, 2012
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fair value assets:
|
|
|
|
|
|
|
|
||||||||
|
Available-for-sale fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
—
|
|
|
$
|
7,534
|
|
|
$
|
—
|
|
|
$
|
7,534
|
|
|
Foreign government
|
—
|
|
|
117,392
|
|
|
—
|
|
|
117,392
|
|
||||
|
States and political subdivisions
|
—
|
|
|
34,753
|
|
|
—
|
|
|
34,753
|
|
||||
|
Corporates
|
1,301
|
|
|
1,392,446
|
|
|
3,379
|
|
|
1,397,126
|
|
||||
|
Mortgage- and asset-backed securities
|
—
|
|
|
328,415
|
|
|
1,794
|
|
|
330,209
|
|
||||
|
Total available-for-sale fixed-maturity securities
|
1,301
|
|
|
1,880,540
|
|
|
5,173
|
|
|
1,887,014
|
|
||||
|
Available-for-sale equity securities
|
26,608
|
|
|
10,491
|
|
|
48
|
|
|
37,147
|
|
||||
|
Trading securities
|
—
|
|
|
7,762
|
|
|
—
|
|
|
7,762
|
|
||||
|
Separate accounts
|
—
|
|
|
2,618,115
|
|
|
—
|
|
|
2,618,115
|
|
||||
|
Total fair value assets
|
$
|
27,909
|
|
|
$
|
4,516,908
|
|
|
$
|
5,221
|
|
|
$
|
4,550,038
|
|
|
Fair value liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Currency swaps
|
$
|
—
|
|
|
$
|
2,048
|
|
|
$
|
—
|
|
|
$
|
2,048
|
|
|
Separate accounts
|
—
|
|
|
2,618,115
|
|
|
—
|
|
|
2,618,115
|
|
||||
|
Total fair value liabilities
|
$
|
—
|
|
|
$
|
2,620,163
|
|
|
$
|
—
|
|
|
$
|
2,620,163
|
|
|
|
Year ended December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Level 3 assets, beginning of period
|
$
|
5,221
|
|
|
$
|
6,937
|
|
|
Net unrealized gains (losses) through other comprehensive income
|
(116
|
)
|
|
(235
|
)
|
||
|
Net realized gains (losses) included in realized investment gains (losses), including OTTI losses
|
(278
|
)
|
|
(18
|
)
|
||
|
Purchases
(1)
|
2
|
|
|
1,484
|
|
||
|
Sales
|
—
|
|
|
(3,466
|
)
|
||
|
Settlements
|
(314
|
)
|
|
—
|
|
||
|
Transfers into level 3
|
25
|
|
|
521
|
|
||
|
Transfers out of level 3
|
(2,252
|
)
|
|
(2
|
)
|
||
|
Level 3 assets, end of period
|
$
|
2,288
|
|
|
$
|
5,221
|
|
|
(1)
|
Invested assets that are initially valued using level 3 inputs upon purchase and subsequently are able to be priced using level 2 inputs within the year of purchase are classified as level 2 assets and are excluded from the rollforward of level 3 assets presented.
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
|
Carrying
value
|
|
Estimated
fair value
|
|
Carrying
value
|
|
Estimated
fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities available for sale
|
$
|
1,755,712
|
|
|
$
|
1,755,712
|
|
|
$
|
1,887,014
|
|
|
$
|
1,887,014
|
|
|
Equity securities available for sale
|
39,894
|
|
|
39,894
|
|
|
37,147
|
|
|
37,147
|
|
||||
|
Trading securities
|
12,991
|
|
|
12,991
|
|
|
7,762
|
|
|
7,762
|
|
||||
|
Policy loans
|
26,806
|
|
|
26,806
|
|
|
24,613
|
|
|
24,613
|
|
||||
|
Deposit asset underlying 10% Coinsurance Agreement
|
124,413
|
|
|
124,413
|
|
|
91,524
|
|
|
91,524
|
|
||||
|
Separate accounts
|
2,503,829
|
|
|
2,503,829
|
|
|
2,618,115
|
|
|
2,618,115
|
|
||||
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Notes payable
|
$
|
374,481
|
|
|
$
|
385,161
|
|
|
$
|
374,433
|
|
|
$
|
418,777
|
|
|
Currency swaps
|
88
|
|
|
88
|
|
|
2,048
|
|
|
2,048
|
|
||||
|
Separate accounts
|
2,503,829
|
|
|
2,503,829
|
|
|
2,618,115
|
|
|
2,618,115
|
|
||||
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(Dollars in thousands)
|
||||||
|
Direct life insurance in force
|
$
|
679,337,825
|
|
|
$
|
675,164,992
|
|
|
Amounts ceded to other companies
|
(601,309,340
|
)
|
|
(599,133,626
|
)
|
||
|
Net life insurance in force
|
$
|
78,028,485
|
|
|
$
|
76,031,366
|
|
|
Percentage of reinsured life insurance in force
|
89
|
%
|
|
89
|
%
|
||
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||
|
Reinsurance
receivable
|
|
A.M. Best
rating
|
|
Reinsurance
receivable
|
|
A.M. Best
rating
|
|||||
|
(In thousands)
|
|||||||||||
|
Prime Re
(1)
|
$
|
2,572,800
|
|
|
NR
|
|
$
|
2,505,157
|
|
|
NR
|
|
SCOR Global Life Reinsurance
(3)
|
372,479
|
|
|
A
|
|
387,397
|
|
|
A
|
||
|
Financial Reassurance Company 2010, Ltd.
(1)
|
343,144
|
|
|
NR
|
|
352,073
|
|
|
NR
|
||
|
Swiss Re Life & Health America Inc.
(2)
|
260,775
|
|
|
A+
|
|
266,841
|
|
|
A+
|
||
|
American Health and Life Insurance Company
(1)
|
174,722
|
|
|
A-
|
|
174,905
|
|
|
A-
|
||
|
Munich American Reassurance Company
|
100,856
|
|
|
A+
|
|
101,349
|
|
|
A+
|
||
|
Korean Reinsurance Company
|
89,405
|
|
|
A
|
|
86,287
|
|
|
A
|
||
|
RGA Reinsurance Company
|
75,629
|
|
|
A+
|
|
72,230
|
|
|
A+
|
||
|
Toa Reinsurance Company
|
18,824
|
|
|
A+
|
|
15,612
|
|
|
A+
|
||
|
Hannover Life Reassurance Company
|
16,862
|
|
|
A+
|
|
15,078
|
|
|
A+
|
||
|
All other reinsurers
|
29,558
|
|
|
—
|
|
28,265
|
|
|
—
|
||
|
Due from reinsurers
|
$
|
4,055,054
|
|
|
|
|
$
|
4,005,194
|
|
|
|
|
(1)
|
Reinsurers are affiliates of Citigroup. Amounts shown are net of their share of the reinsurance receivable from other reinsurers.
|
|
(2)
|
Includes amounts ceded to Lincoln National Life Insurance Company and
100%
retroceded to Swiss Re Life & Health America Inc.
|
|
(3)
|
Includes amounts ceded to Generali USA Life Reassurance Company due to its purchase by the parent company of SCOR Global Life Reinsurance Companies in October 2013 and amounts retroceded from Transamerica Reinsurance Companies. Generali USA Life Reassurance Company held a strength rating of A- as of December 31, 2012.
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
DAC balance, beginning of period
|
$
|
1,066,422
|
|
|
$
|
904,485
|
|
|
$
|
738,946
|
|
|
Capitalization
|
283,341
|
|
|
276,840
|
|
|
270,661
|
|
|||
|
Amortization
|
(129,183
|
)
|
|
(118,598
|
)
|
|
(104,034
|
)
|
|||
|
Foreign exchange and other
|
(12,114
|
)
|
|
3,695
|
|
|
(1,088
|
)
|
|||
|
DAC balance, end of period
|
$
|
1,208,466
|
|
|
$
|
1,066,422
|
|
|
$
|
904,485
|
|
|
|
December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Policy claims and other benefits payable, beginning of period
|
$
|
254,533
|
|
|
$
|
241,754
|
|
|
$
|
229,895
|
|
|
Less reinsured policy claims and other benefits payable
|
269,279
|
|
|
236,930
|
|
|
233,346
|
|
|||
|
Net balance, beginning of period
|
(14,746
|
)
|
|
4,824
|
|
|
(3,451
|
)
|
|||
|
Incurred related to current year
|
147,639
|
|
|
150,352
|
|
|
142,685
|
|
|||
|
Incurred related to prior year
|
(4,956
|
)
|
|
(3,208
|
)
|
|
391
|
|
|||
|
Total incurred
|
142,683
|
|
|
147,144
|
|
|
143,076
|
|
|||
|
Claims paid related to current year, net of reinsured policy claims received
|
(150,922
|
)
|
|
(183,208
|
)
|
|
(153,540
|
)
|
|||
|
Reinsured policy claims received related to prior year, net of claims paid
|
28,601
|
|
|
16,307
|
|
|
18,945
|
|
|||
|
Total paid
|
(122,321
|
)
|
|
(166,901
|
)
|
|
(134,595
|
)
|
|||
|
Foreign currency
|
(497
|
)
|
|
187
|
|
|
(206
|
)
|
|||
|
Net balance, end of period
|
5,119
|
|
|
(14,746
|
)
|
|
4,824
|
|
|||
|
Add reinsured policy claims and other benefits payable
|
248,185
|
|
|
269,279
|
|
|
236,930
|
|
|||
|
Balance, end of period
|
$
|
253,304
|
|
|
$
|
254,533
|
|
|
$
|
241,754
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||||
|
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
4.75% Senior notes payable, due July 15, 2022
|
$
|
375,000
|
|
|
4.75
|
%
|
|
$
|
375,000
|
|
|
4.75
|
%
|
|
Unamortized issuance discount on notes payable
|
(519
|
)
|
|
|
|
(567
|
)
|
|
|
||||
|
Total notes payable
|
$
|
374,481
|
|
|
|
|
$
|
374,433
|
|
|
|
||
|
|
Current
|
|
Deferred
|
|
Total
|
||||||
|
|
(In thousands)
|
||||||||||
|
Year Ended December 31, 2013
|
|
|
|
|
|
||||||
|
Federal
|
$
|
35,966
|
|
|
$
|
32,919
|
|
|
$
|
68,885
|
|
|
Foreign
|
32,797
|
|
|
(14,410
|
)
|
|
18,387
|
|
|||
|
State and local
|
1,377
|
|
|
(176
|
)
|
|
1,201
|
|
|||
|
Total tax expense (benefit)
|
$
|
70,140
|
|
|
$
|
18,333
|
|
|
$
|
88,473
|
|
|
|
|
|
|
|
|
||||||
|
Year Ended December 31, 2012
|
|
|
|
|
|
||||||
|
Federal
|
$
|
51,301
|
|
|
$
|
24,517
|
|
|
$
|
75,818
|
|
|
Foreign
|
26,836
|
|
|
(11,130
|
)
|
|
15,706
|
|
|||
|
State and local
|
1,613
|
|
|
(55
|
)
|
|
1,558
|
|
|||
|
Total tax expense (benefit)
|
$
|
79,750
|
|
|
$
|
13,332
|
|
|
$
|
93,082
|
|
|
|
|
|
|
|
|
||||||
|
Year Ended December 31, 2011
|
|
|
|
|
|
||||||
|
Federal
|
$
|
58,542
|
|
|
$
|
9,020
|
|
|
$
|
67,562
|
|
|
Foreign
|
30,807
|
|
|
(12,280
|
)
|
|
18,527
|
|
|||
|
State and local
|
793
|
|
|
(164
|
)
|
|
629
|
|
|||
|
Total tax expense (benefit)
|
$
|
90,142
|
|
|
$
|
(3,424
|
)
|
|
$
|
86,718
|
|
|
|
Year ended December 31,
|
|||||||||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
|||||||||||||||
|
|
Amount
|
|
Percentage
|
|
Amount
|
|
Percentage
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
(Dollars in thousands)
|
|||||||||||||||||||
|
Computed tax expense
|
$
|
87,918
|
|
|
35.0
|
%
|
|
$
|
93,411
|
|
|
35.0
|
%
|
|
$
|
85,368
|
|
|
35.0
|
%
|
|
Other
|
555
|
|
|
0.2
|
%
|
|
(329
|
)
|
|
(0.1
|
)%
|
|
1,350
|
|
|
0.6
|
%
|
|||
|
Total tax expense/effective rate
|
$
|
88,473
|
|
|
35.2
|
%
|
|
$
|
93,082
|
|
|
34.9
|
%
|
|
$
|
86,718
|
|
|
35.6
|
%
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Deferred tax assets:
|
|
|
|
||||
|
Future policy benefit reserves and unpaid policy claims
|
$
|
207,662
|
|
|
$
|
187,166
|
|
|
Intangibles and tax goodwill
|
48,694
|
|
|
46,819
|
|
||
|
Future deductible liabilities
|
27,606
|
|
|
17,457
|
|
||
|
Other
|
14,656
|
|
|
21,041
|
|
||
|
Total deferred tax assets
|
298,618
|
|
|
272,483
|
|
||
|
Deferred tax liabilities:
|
|
|
|
||||
|
Deferred policy acquisition costs
|
(269,534
|
)
|
|
(248,208
|
)
|
||
|
Investments
|
(26,010
|
)
|
|
(42,739
|
)
|
||
|
Distributable unremitted earnings of foreign subsidiaries
|
(2,848
|
)
|
|
(2,924
|
)
|
||
|
Reinsurance deposit asset
|
(43,544
|
)
|
|
(32,033
|
)
|
||
|
Other
|
(15,098
|
)
|
|
(15,527
|
)
|
||
|
Total deferred tax liabilities
|
(357,034
|
)
|
|
(341,431
|
)
|
||
|
Net deferred tax liabilities
|
$
|
(58,416
|
)
|
|
$
|
(68,948
|
)
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Unrecognized tax benefits, beginning of period
|
$
|
20,996
|
|
|
$
|
21,356
|
|
|
Change in prior period unrecognized tax benefits
|
32
|
|
|
182
|
|
||
|
Change in current period unrecognized tax benefits
|
2,108
|
|
|
2,178
|
|
||
|
Reductions as a result of a lapse in statute of limitations
|
(6,529
|
)
|
|
(2,720
|
)
|
||
|
Unrecognized tax benefits, end of period
|
$
|
16,607
|
|
|
$
|
20,996
|
|
|
|
Year ended December 31,
|
|||||||
|
|
2013
|
|
2012
|
|
2011
|
|||
|
|
(In thousands)
|
|||||||
|
Balance, beginning of period
|
56,374
|
|
|
64,883
|
|
|
72,843
|
|
|
Shares of restricted common stock issued, net
|
280
|
|
|
438
|
|
|
348
|
|
|
Shares of common stock issued upon lapse of RSUs
|
1,122
|
|
|
998
|
|
|
784
|
|
|
Common stock retired
|
(2,942
|
)
|
|
(9,945
|
)
|
|
(9,092
|
)
|
|
Common stock, end of period
|
54,834
|
|
|
56,374
|
|
|
64,883
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||
|
Basic EPS:
|
|
|
|
|
|
||||||
|
Numerator:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Income attributable to unvested participating securities
|
(2,671
|
)
|
|
(4,650
|
)
|
|
(4,906
|
)
|
|||
|
Net income used in calculating basic EPS
|
$
|
160,054
|
|
|
$
|
169,156
|
|
|
$
|
152,285
|
|
|
Denominator:
|
|
|
|
|
|
||||||
|
Weighted-average vested shares
|
55,834
|
|
|
61,059
|
|
|
72,283
|
|
|||
|
Basic EPS
|
$
|
2.87
|
|
|
$
|
2.77
|
|
|
$
|
2.11
|
|
|
|
|
|
|
|
|
||||||
|
Diluted EPS:
|
|
|
|
|
|
||||||
|
Numerator:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Income attributable to unvested participating securities
|
(2,640
|
)
|
|
(4,561
|
)
|
|
(4,855
|
)
|
|||
|
Net income used in calculating diluted EPS
|
$
|
160,085
|
|
|
$
|
169,245
|
|
|
$
|
152,336
|
|
|
Denominator:
|
|
|
|
|
|
||||||
|
Weighted-average vested shares
|
55,834
|
|
|
61,059
|
|
|
72,283
|
|
|||
|
Dilutive effect of incremental shares if issued for warrants outstanding
|
787
|
|
|
1,342
|
|
|
824
|
|
|||
|
Dilutive effect of incremental shares to be issued for stock options
|
4
|
|
|
—
|
|
|
—
|
|
|||
|
Weighted-average shares used in calculating diluted EPS
|
56,625
|
|
|
62,401
|
|
|
73,107
|
|
|||
|
Diluted EPS
|
$
|
2.83
|
|
|
$
|
2.71
|
|
|
$
|
2.08
|
|
|
|
|
|
Weighted-average measurement-date fair value per share
|
|||
|
|
Shares
|
|
||||
|
|
(Shares in thousands)
|
|||||
|
Unvested employee and director restricted stock and RSUs, December 31, 2010
|
2,566
|
|
|
$
|
15.02
|
|
|
Granted
|
368
|
|
|
25.65
|
|
|
|
Forfeited
|
(12
|
)
|
|
18.25
|
|
|
|
Vested
|
(858
|
)
|
|
15.04
|
|
|
|
Unvested employee and director restricted stock and RSUs, December 31, 2011
|
2,064
|
|
|
16.88
|
|
|
|
Granted
|
458
|
|
|
25.40
|
|
|
|
Forfeited
|
(13
|
)
|
|
22.70
|
|
|
|
Vested
|
(1,002
|
)
|
|
16.43
|
|
|
|
Unvested employee and director restricted stock and RSUs, December 31, 2012
|
1,507
|
|
|
19.72
|
|
|
|
Granted
|
322
|
|
|
32.76
|
|
|
|
Forfeited
|
(9
|
)
|
|
28.72
|
|
|
|
Vested
|
(1,098
|
)
|
|
17.59
|
|
|
|
Unvested employee and director restricted stock and RSUs, December 31, 2013
|
722
|
|
|
28.67
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Expense for management and director restricted stock and RSU awards granted in 2010
|
$
|
3,200
|
|
|
$
|
12,485
|
|
|
$
|
13,389
|
|
|
Expense for management and director restricted stock and RSU awards granted in 2011
|
3,133
|
|
|
3,050
|
|
|
2,750
|
|
|||
|
Expense for management and director restricted stock and RSU awards granted in 2012
|
3,738
|
|
|
3,409
|
|
|
—
|
|
|||
|
Expense for management and director restricted stock and RSU awards granted in 2013
|
3,030
|
|
|
—
|
|
|
—
|
|
|||
|
Total management and director restricted stock and RSU awards expense
|
$
|
13,101
|
|
|
$
|
18,944
|
|
|
$
|
16,139
|
|
|
Tax benefit associated with total management and director restricted stock and RSU award expense
|
$
|
3,936
|
|
|
$
|
4,533
|
|
|
$
|
5,530
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Expense recognized for stock option awards
|
$
|
323
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Tax benefit recognized for stock option awards
|
$
|
113
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Year Ended December 31, 2013
|
||
|
Expected volatility
|
30.00
|
%
|
|
|
Expected per share dividend yield
|
1.35
|
%
|
|
|
Risk-free interest rate
|
1.06
|
%
|
|
|
Expected term of options using simplified method
|
6 years
|
|
|
|
Fair value per option
|
$
|
8.44
|
|
|
|
|
|
Weighted-average measurement-date fair value per share
|
|||
|
|
Shares
|
|
||||
|
|
(Shares in thousands)
|
|||||
|
Unvested non-employee RSUs, December 31, 2010
|
188
|
|
|
$
|
19.37
|
|
|
Granted
|
517
|
|
|
17.17
|
|
|
|
Vested
|
(588
|
)
|
|
17.70
|
|
|
|
Unvested non-employee RSUs, December 31, 2011
|
117
|
|
|
17.55
|
|
|
|
Granted
|
379
|
|
|
22.94
|
|
|
|
Vested
|
(364
|
)
|
|
20.38
|
|
|
|
Unvested non-employee RSUs, December 31, 2012
|
132
|
|
|
25.42
|
|
|
|
Granted
|
504
|
|
|
32.14
|
|
|
|
Vested
|
(532
|
)
|
|
29.64
|
|
|
|
Unvested non-employee RSUs, December 31, 2013
|
104
|
|
|
36.44
|
|
|
|
|
Year ended December 31,
|
||||
|
|
2013
|
|
2012
|
|
2011
|
|
Expected volatility
|
20% to 35%
|
|
20% to 50%
|
|
29% to 67%
|
|
Quarterly dividends expected
|
$0.11
|
|
$0.03 to $0.09
|
|
$0.01 to $0.03
|
|
Risk-free interest rates
|
Less than 2%
|
|
Less than 1%
|
|
Less than 1%
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(Dollars in thousands, except per-share amounts)
|
||||||||||
|
Total quarterly non-employee RSUs granted
|
503,737
|
|
|
378,505
|
|
|
517,374
|
|
|||
|
Measurement date per-share fair value of awards
|
$26.39 to $36.44
|
|
|
$20.36 to $25.42
|
|
|
$14.08 to $21.06
|
|
|||
|
Illiquidity discounts
|
13% to 18%
|
|
|
17% to 32%
|
|
|
17% to 32%
|
|
|||
|
Quarterly incentive awards expense recognized
|
$
|
364
|
|
|
$
|
—
|
|
|
$
|
1,747
|
|
|
Quarterly incentive awards expense deferred
|
$
|
15,818
|
|
|
$
|
8,686
|
|
|
$
|
7,058
|
|
|
Concurrent tax benefit of deferred expense
|
$
|
5,001
|
|
|
$
|
2,640
|
|
|
$
|
2,273
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||
|
|
(in thousands)
|
||||||
|
Statutory capital and surplus
|
$
|
563,260
|
|
|
$
|
670,434
|
|
|
Statutory unassigned surplus
|
99,707
|
|
|
231,316
|
|
||
|
|
December 31, 2013
|
||
|
|
(In thousands)
|
||
|
2014
|
$
|
6,933
|
|
|
2015
|
6,304
|
|
|
|
2016
|
6,270
|
|
|
|
2017
|
6,297
|
|
|
|
2018
|
5,549
|
|
|
|
Thereafter
|
50,738
|
|
|
|
Total minimum rental commitments for operating leases
|
$
|
82,091
|
|
|
|
Quarter ended March 31,
2013 |
|
Quarter ended June 30,
2013 |
|
Quarter ended September 30,
2013 |
|
Quarter ended December 31,
2013 |
||||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||||||
|
Direct premiums
|
$
|
570,899
|
|
|
$
|
577,208
|
|
|
576,095
|
|
|
$
|
577,866
|
|
|
|
Ceded premiums
|
(410,604
|
)
|
|
(417,450
|
)
|
|
(407,488
|
)
|
|
(408,615
|
)
|
||||
|
Net premiums
|
160,295
|
|
|
159,758
|
|
|
168,607
|
|
|
169,251
|
|
||||
|
Commissions and fees
|
112,273
|
|
|
117,183
|
|
|
118,443
|
|
|
123,910
|
|
||||
|
Net investment income
|
23,216
|
|
|
21,027
|
|
|
22,103
|
|
|
22,407
|
|
||||
|
Realized investment gains (losses), including OTTI
|
2,286
|
|
|
3,468
|
|
|
(407
|
)
|
|
899
|
|
||||
|
Other, net
|
10,375
|
|
|
10,871
|
|
|
10,711
|
|
|
10,773
|
|
||||
|
Total revenues
|
308,445
|
|
|
312,307
|
|
|
319,457
|
|
|
327,240
|
|
||||
|
Total benefits and expenses
|
248,213
|
|
|
244,861
|
|
|
252,903
|
|
|
270,274
|
|
||||
|
Income before income taxes
|
60,232
|
|
|
67,446
|
|
|
66,554
|
|
|
56,966
|
|
||||
|
Income taxes
|
21,387
|
|
|
23,956
|
|
|
23,364
|
|
|
19,765
|
|
||||
|
Net income
|
$
|
38,845
|
|
|
$
|
43,490
|
|
|
$
|
43,190
|
|
|
$
|
37,201
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per share — basic
|
$
|
0.67
|
|
|
$
|
0.76
|
|
|
$
|
0.78
|
|
|
$
|
0.67
|
|
|
Earnings per share — diluted
|
$
|
0.65
|
|
|
$
|
0.74
|
|
|
$
|
0.78
|
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Quarter ended March 31,
2012 |
|
Quarter ended June 30,
2012 |
|
Quarter ended September 30,
2012 |
|
Quarter ended December 31,
2012 |
||||||||
|
|
(In thousands, except per-share amounts)
|
||||||||||||||
|
Direct premiums
|
$
|
561,037
|
|
|
$
|
570,073
|
|
|
$
|
567,273
|
|
|
$
|
569,592
|
|
|
Ceded premiums
|
(418,163
|
)
|
|
(415,815
|
)
|
|
(414,991
|
)
|
|
(414,784
|
)
|
||||
|
Net premiums
|
142,874
|
|
|
154,258
|
|
|
152,282
|
|
|
154,808
|
|
||||
|
Commissions and fees
|
104,261
|
|
|
107,107
|
|
|
104,607
|
|
|
113,069
|
|
||||
|
Net investment income
|
26,097
|
|
|
23,605
|
|
|
26,881
|
|
|
24,221
|
|
||||
|
Realized investment gains (losses), including OTTI
|
2,131
|
|
|
4,321
|
|
|
3,872
|
|
|
1,058
|
|
||||
|
Other, net
|
11,238
|
|
|
11,234
|
|
|
11,446
|
|
|
11,345
|
|
||||
|
Total revenues
|
286,601
|
|
|
300,525
|
|
|
299,088
|
|
|
304,501
|
|
||||
|
Total benefits and expenses
|
223,136
|
|
|
228,604
|
|
|
228,532
|
|
|
243,555
|
|
||||
|
Income before income taxes
|
63,465
|
|
|
71,921
|
|
|
70,556
|
|
|
60,946
|
|
||||
|
Income taxes
|
21,709
|
|
|
25,741
|
|
|
24,957
|
|
|
20,675
|
|
||||
|
Net income
|
$
|
41,756
|
|
|
$
|
46,180
|
|
|
$
|
45,599
|
|
|
$
|
40,271
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per share — basic
|
$
|
0.62
|
|
|
$
|
0.73
|
|
|
$
|
0.74
|
|
|
$
|
0.68
|
|
|
Earnings per share — diluted
|
$
|
0.61
|
|
|
$
|
0.72
|
|
|
$
|
0.72
|
|
|
$
|
0.67
|
|
|
•
|
Matters to be Voted on — Election of Ten Directors;
|
|
•
|
Corporate Governance — Independence of Committee Members;
|
|
•
|
Corporate Governance — Code of Conduct;
|
|
•
|
Corporate Governance — Section 16(a) Beneficial Ownership Reporting Compliance;
|
|
•
|
Board of Directors — Members of Our Board of Directors;
|
|
•
|
Board of Directors — Committees of Our Board of Directors;
|
|
•
|
Board of Directors — Director Legal Matters;
|
|
•
|
Executive Compensation — Employment Agreements with Named Executive Officers;
|
|
•
|
Audit Committee Matters — Audit Committee Report;
|
|
•
|
Related Party Transactions — Transactions with Citigroup; and
|
|
•
|
Related Party Transactions — Transactions with Warburg Pincus.
|
|
•
|
Board of Directors — Committees of Our Board of Directors — Compensation Committee;
|
|
•
|
Board of Directors — Director Compensation; and
|
|
•
|
Executive Compensation.
|
|
•
|
Corporate Governance — Beneficial Ownership of Common Stock.
|
|
•
|
Introductory paragraph to Corporate Governance;
|
|
•
|
Corporate Governance — Independence of Directors;
|
|
•
|
Corporate Governance — Categorical Standards of Independence;
|
|
•
|
Corporate Governance — Independence of Committee Members;
|
|
•
|
Board of Directors — Committees of Our Board of Directors; and
|
|
•
|
Related Party Transactions.
|
|
•
|
Matters to be Voted on — Proposal 3: Ratification of the Appointment of KPMG LLP as Our Independent Registered Public Accounting Firm;
|
|
•
|
Board of Directors — Committees of Our Board of Directors — Audit Committee; and
|
|
•
|
Audit Committee Matters — Fees and Services of Our Independent Registered Public Accounting Firm.
|
|
•
|
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
•
|
have been qualified by disclosures that were made to the other party in connection with the negotiation of the application agreement, which disclosures are not necessarily reflected in the agreement;
|
|
•
|
may apply standards of materiality in a way that is different from what may be viewed as material to our investors; and
|
|
•
|
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
|
|
Exhibit
Number
|
|
Description
|
|
Reference
|
|
|
|
|
|
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation of the Registrant.
|
|
Incorporated by reference to Exhibit 3.1 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680).
|
|
3.2
|
|
Amended and Restated Bylaws of the Registrant.
|
|
Incorporated by reference to Exhibit 3.2 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680).
|
|
4.1
|
|
Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee.
|
|
Incorporated by reference to Exhibit 4.1 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
4.2
|
|
First Supplemental Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee.
|
|
Incorporated by reference to Exhibit 4.2 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
4.3
|
|
Form of 4.750% Senior Notes due 2022.
|
|
Incorporated by reference to Exhibit 4.3 (included in Exhibit 4.2 filed herewith) to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
10.1
|
|
Tax Separation Agreement dated as of March 30, 2010 by and between the Registrant and Citigroup Inc.
|
|
Incorporated by reference to Exhibit 10.3 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.2
|
|
80% Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company and Prime Reinsurance Company, Inc.
|
|
Incorporated by reference to Exhibit 10.5 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.3
|
|
10% Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company and Prime Reinsurance Company, Inc.
|
|
Incorporated by reference to Exhibit 10.6 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.4
|
|
80% Coinsurance Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon.
|
|
Incorporated by reference to Exhibit 10.7 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.5
|
|
10% Coinsurance Economic Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon.
|
|
Incorporated by reference to Exhibit 10.8 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.6
|
|
10% Coinsurance Excess Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon.
|
|
Incorporated by reference to Exhibit 10.9 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.7
|
|
Capital Maintenance Agreement dated March 31, 2010 by and between Citigroup Inc. and Prime Reinsurance Company, Inc.
|
|
Incorporated by reference to Exhibit 10.10 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.8
|
|
90% Coinsurance Agreement dated March 31, 2010 by and between National Benefit Life Insurance Company and American Health and Life Insurance Company.
|
|
Incorporated by reference to Exhibit 10.11 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.9
|
|
Trust Agreement dated March 29, 2010 among National Benefit Life Insurance Company, American Health and Life Insurance Company and The Bank of New York Mellon.
|
|
Incorporated by reference to Exhibit 10.12 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.10
|
|
Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company of Canada and Financial Reassurance Company 2010, Ltd.
|
|
Incorporated by reference to Exhibit 10.13 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
Exhibit
Number
|
|
Description
|
|
Reference
|
|
10.11
|
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among Primerica Life Insurance Company and Prime Reinsurance Company, Inc.
|
|
Incorporated by reference to Exhibit 10.41 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.12
|
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among National Benefit Life Insurance Company and American Health and Life Insurance Company.
|
|
Incorporated by reference to Exhibit 10.42 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.13
|
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among Primerica Life Insurance Company of Canada and Financial Reassurance Company 2010 Ltd.
|
|
Incorporated by reference to Exhibit 10.43 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.14
|
|
Occupancy Services Agreement dated as of April 7, 2010, between National Benefit Life Insurance Company and Citibank, N.A.
|
|
Incorporated by reference to Exhibit 10.19 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680).
|
|
10.15
|
|
Amendment No. 1 dated as of October 7, 2011 to Occupancy Services Agreement dated as of April 7, 2010, between National Benefit Life Insurance Company and Citibank, N.A.
|
|
Incorporated by reference to Exhibit 10.20 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680).
|
|
10.16
|
|
Primerica, Inc. Stock Purchase Plan for Agents and Employees.
|
|
Incorporated by reference to Exhibit 10.45 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
10.17*
|
|
Primerica, Inc. Amended and Restated 2010 Omnibus Incentive Plan.
|
|
Incorporated by reference to Exhibit 10.22 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680).
|
|
10.18*
|
|
Form of Restricted Stock Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan.
|
|
Incorporated by reference to Exhibit 10.23 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680).
|
|
10.19
|
|
Form of Director Restricted Stock Unit Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
10.20*
|
|
Form of Non-Qualified Stock Option under the Primerica, Inc. 2010 Omnibus Incentive Plan.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
10.21*
|
|
Form of Restricted Stock Unit Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
10.22*
|
|
Form of Indemnification Agreement for Directors and Officers.
|
|
Incorporated by reference to Exhibit 10.48 to Primerica's Registration Statement on Form S-1 (File No. 333-162918).
|
|
10.23*
|
|
Employment Agreement, dated as of August 19, 2010, between the Registrant and Mr. D. Richard Williams.
|
|
Incorporated by reference to Exhibit 99.1 to Primerica's Current Report on Form 8-K dated August 19, 2010 (Commission File No. 001-34680).
|
|
10.24*
|
|
Employment Agreement, dated as of August 19, 2010, between the Registrant and Mr. John A. Addison, Jr.
|
|
Incorporated by reference to Exhibit 99.2 to Primerica's Current Report on Form 8-K dated August 19, 2010 (Commission File No. 001-34680).
|
|
10.25*
|
|
Amended and Restated Employment Agreement, dated as of February 15, 2013, between the Registrant and Mr. Peter W. Schneider.
|
|
Incorporated by reference to Exhibit 99.1 to Primerica's Current Report on Form 8-K dated February 15, 2013 (Commission File No. 001-34680).
|
|
10.26*
|
|
Amended and Restated Employment Agreement, dated as of February 15, 2013, between the Registrant and Mr. Glenn J. Williams.
|
|
Incorporated by reference to Exhibit 99.2 to Primerica's Current Report on Form 8-K dated February 15, 2013 (Commission File No. 001-34680).
|
|
Exhibit
Number
|
|
Description
|
|
Reference
|
|
10.27*
|
|
Amended and Restated Employment Agreement, dated as of February 15, 2013, between the Registrant and Ms. Alison S. Rand.
|
|
Incorporated by reference to Exhibit 99.3 to Primerica's Current Report on Form 8-K dated February 15, 2013 (Commission File No. 001-34680).
|
|
10.28*
|
|
Amended and Restated Employment Agreement, dated as of February 15, 2013, between the Registrant and Mr. Gregory C. Pitts.
|
|
Incorporated by reference to Exhibit 99.4 to Primerica's Current Report on Form 8-K dated February 15, 2013 (Commission File No. 001-34680).
|
|
10.29
|
|
Nonemployee Directors' Deferred Compensation Plan, effective as of January 1, 2011, adopted on November 10, 2010.
|
|
Incorporated by reference to Exhibit 10.31 to Annual Report on Form 10-K for the year ended December 31, 2010 (Commission File No. 001-34680).
|
|
12.1
|
|
Statement re Computation of Ratios.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
21.1
|
|
Subsidiaries of the Registrant.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
23.1
|
|
Consent of KPMG LLP.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by John A. Addison, Jr., Chairman of Primerica Distribution and Co-Chief Executive Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
31.3
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by Alison S. Rand, Executive Vice President and Chief Financial Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
32.1
|
|
Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350), executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer, John A. Addison, Jr., Chairman of Primerica Distribution and Co-Chief Executive Officer, and Alison S. Rand, Executive Vice President and Chief Financial Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Annual Report.
|
|
101.INS
|
|
XBRL Instance Document
(1)
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Annual Report.
|
|
*
|
Identifies a management contract or compensatory plan or arrangement.
|
|
(1)
|
Includes the following materials contained in this Annual Report on Form 10-K for the year ended
December 31, 2013
, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Comprehensive Income, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements.
|
|
|
|
As of December 31, 2013
|
||||||||||
|
Type of Investment
|
|
Amortized Cost or Cost
|
|
Fair Value
|
|
Amount at which shown in the balance sheet
|
||||||
|
|
|
(In thousands)
|
||||||||||
|
Fixed maturities:
|
|
|
|
|
|
|
||||||
|
Bonds:
|
|
|
|
|
|
|||||||
|
United States Government and government agencies and authorities
|
$
|
8,696
|
|
|
$
|
9,054
|
|
|
$
|
9,054
|
|
|
|
States, municipalities and political subdivisions
|
32,544
|
|
|
33,917
|
|
|
33,917
|
|
||||
|
Foreign governments
|
118,859
|
|
|
123,876
|
|
|
123,876
|
|
||||
|
Public utilities
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Convertibles and bonds with warrants attached
|
6,658
|
|
|
7,223
|
|
|
7,223
|
|
||||
|
All other corporate bonds
|
1,507,324
|
|
|
1,593,020
|
|
|
1,593,020
|
|
||||
|
Certificates of deposit
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Redeemable preferred stocks
|
1,966
|
|
|
1,613
|
|
|
1,613
|
|
||||
|
Total fixed maturities
|
1,676,047
|
|
|
1,768,703
|
|
|
1,768,703
|
|
||||
|
|
|
|
|
|
|
|||||||
|
Equity securities:
|
|
|
|
|
|
|
||||||
|
Common stocks:
|
|
|
|
|
|
|||||||
|
Public utilities
|
9,427
|
|
|
11,787
|
|
|
11,787
|
|
||||
|
Banks, trusts and insurance companies
|
6,795
|
|
|
10,252
|
|
|
10,252
|
|
||||
|
Industrial, miscellaneous and all other
|
8,285
|
|
|
9,787
|
|
|
9,787
|
|
||||
|
Nonredeemable preferred stocks
|
8,085
|
|
|
8,068
|
|
|
8,068
|
|
||||
|
Total equity securities
|
32,592
|
|
|
39,894
|
|
|
39,894
|
|
||||
|
Mortgage loans on real estate
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Real estate
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Policy loans
|
26,806
|
|
|
26,806
|
|
|
26,806
|
|
||||
|
Other long-term investments
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Short-term investments
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total investments
|
$
|
1,735,445
|
|
|
$
|
1,835,403
|
|
|
$
|
1,835,403
|
|
|
|
|
December 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Assets
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Fixed-maturity securities available for sale, at fair value (amortized cost: $62,216 in 2013 and $52,094 in 2012)
|
$
|
62,420
|
|
|
$
|
52,668
|
|
|
Total investments
|
62,420
|
|
|
52,668
|
|
||
|
Cash and cash equivalents
|
11,361
|
|
|
10,296
|
|
||
|
Due from affiliates*
|
76
|
|
|
176
|
|
||
|
Other receivables
|
364
|
|
|
376
|
|
||
|
Deferred income taxes
|
5,762
|
|
|
4,235
|
|
||
|
Investment in subsidiaries*
|
1,528,360
|
|
|
1,597,896
|
|
||
|
Other assets
|
2,801
|
|
|
3,153
|
|
||
|
Total assets
|
$
|
1,611,144
|
|
|
$
|
1,668,800
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Notes payable
|
$
|
374,481
|
|
|
$
|
374,433
|
|
|
Current income tax payable
|
2,185
|
|
|
7,069
|
|
||
|
Deferred income taxes
|
3,797
|
|
|
2,836
|
|
||
|
Due to affiliates*
|
168
|
|
|
604
|
|
||
|
Interest payable
|
8,214
|
|
|
8,164
|
|
||
|
Other liabilities
|
272
|
|
|
278
|
|
||
|
Commitments and contingent liabilities (see Note F)
|
|
|
|
||||
|
Total liabilities
|
389,117
|
|
|
393,384
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Common stock ($.01 par value, authorized 500,000 in 2013 and 2012 and issued 54,834 shares in 2013 and 56,374 shares in 2012)
|
548
|
|
|
564
|
|
||
|
Paid-in capital
|
472,633
|
|
|
602,269
|
|
||
|
Retained earnings
|
640,840
|
|
|
503,173
|
|
||
|
Accumulated other comprehensive income, net of income tax
|
108,006
|
|
|
169,410
|
|
||
|
Total stockholders’ equity
|
1,222,027
|
|
|
1,275,416
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
1,611,144
|
|
|
$
|
1,668,800
|
|
|
*
|
Eliminated in consolidation.
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Dividends from subsidiaries*
|
$
|
228,319
|
|
|
$
|
238,747
|
|
|
$
|
275,250
|
|
|
Net investment income
|
762
|
|
|
1,074
|
|
|
61
|
|
|||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
11
|
|
|
545
|
|
|
(5
|
)
|
|||
|
Total revenues
|
229,092
|
|
|
240,366
|
|
|
275,306
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Interest expense
|
18,172
|
|
|
17,266
|
|
|
16,500
|
|
|||
|
Other operating expenses
|
7,882
|
|
|
8,222
|
|
|
8,554
|
|
|||
|
Total expenses
|
26,054
|
|
|
25,488
|
|
|
25,054
|
|
|||
|
Income (loss) before income taxes
|
203,038
|
|
|
214,878
|
|
|
250,252
|
|
|||
|
Income taxes
|
(7,043
|
)
|
|
(5,998
|
)
|
|
(7,131
|
)
|
|||
|
Income (loss) before equity in undistributed earnings of subsidiaries
|
210,081
|
|
|
220,876
|
|
|
257,383
|
|
|||
|
Equity in undistributed earnings of subsidiaries*
|
(47,356
|
)
|
|
(47,070
|
)
|
|
(100,192
|
)
|
|||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
*
|
Eliminated in consolidation.
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Other comprehensive income (loss) before income taxes:
|
|
|
|
|
|
||||||
|
Unrealized investment gains (losses):
|
|
|
|
|
|
||||||
|
Equity in unrealized holding gains (losses) on investment securities held by subsidiaries
|
(47,651
|
)
|
|
18,127
|
|
|
(625
|
)
|
|||
|
Change in unrealized holding gains (losses) on investment securities
|
(358
|
)
|
|
1,127
|
|
|
(13
|
)
|
|||
|
Reclassification adjustment for realized investment (gains) losses included in net income
|
(11
|
)
|
|
(545
|
)
|
|
5
|
|
|||
|
Foreign currency translation adjustments:
|
|
|
|
|
|
||||||
|
Equity in unrealized foreign currency translation gains of subsidiaries
|
(13,695
|
)
|
|
4,221
|
|
|
(3,645
|
)
|
|||
|
Total other comprehensive income (loss) before income taxes
|
(61,715
|
)
|
|
22,930
|
|
|
(4,278
|
)
|
|||
|
Income tax expense (benefit) related to items of other comprehensive income (loss)
|
(311
|
)
|
|
185
|
|
|
(3
|
)
|
|||
|
Other comprehensive income (loss), net of income taxes
|
(61,404
|
)
|
|
22,745
|
|
|
(4,275
|
)
|
|||
|
Total comprehensive income
|
$
|
101,321
|
|
|
$
|
196,551
|
|
|
$
|
152,916
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2013
|
|
2012
|
|
2011
|
||||||
|
|
(In thousands)
|
||||||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
162,725
|
|
|
$
|
173,806
|
|
|
$
|
157,191
|
|
|
Adjustments to reconcile net income to cash provided by (used in) operating activities:
|
|
|
|
|
|
||||||
|
Equity in undistributed earnings of subsidiaries*
|
47,356
|
|
|
47,070
|
|
|
100,192
|
|
|||
|
Non-cash securities dividends received from subsidiaries*
|
—
|
|
|
—
|
|
|
(21,742
|
)
|
|||
|
Deferred tax provision
|
(227
|
)
|
|
(1,139
|
)
|
|
2,533
|
|
|||
|
Change in income taxes
|
(4,912
|
)
|
|
2,451
|
|
|
3,283
|
|
|||
|
Realized investment (gains) losses, including other-than-temporary impairments
|
(11
|
)
|
|
(545
|
)
|
|
5
|
|
|||
|
Accretion and amortization of investments
|
60
|
|
|
400
|
|
|
40
|
|
|||
|
Depreciation and amortization
|
23
|
|
|
183
|
|
|
—
|
|
|||
|
Share-based compensation
|
718
|
|
|
215
|
|
|
196
|
|
|||
|
Change in due to/from affiliates*
|
(336
|
)
|
|
438
|
|
|
(907
|
)
|
|||
|
Change in other operating assets and liabilities, net
|
290
|
|
|
(109
|
)
|
|
(161
|
)
|
|||
|
Net cash provided by (used in) operating activities
|
205,686
|
|
|
222,770
|
|
|
240,630
|
|
|||
|
Cash flows from investing activities:
|
|
|
|
|
|
||||||
|
Available-for-sale investments sold, matured or called:
|
|
|
|
|
|
||||||
|
Fixed-maturity securities — sold
|
2,679
|
|
|
67,267
|
|
|
—
|
|
|||
|
Fixed-maturity securities — matured or called
|
20,269
|
|
|
24,503
|
|
|
5,210
|
|
|||
|
Available-for-sale investments acquired:
|
|
|
|
|
|
||||||
|
Fixed-maturity securities
|
(33,118
|
)
|
|
(120,642
|
)
|
(1)
|
(6,590
|
)
|
|||
|
Other, net
|
—
|
|
|
(70
|
)
|
|
—
|
|
|||
|
Net cash provided by (used in) investing activities
|
(10,170
|
)
|
|
(28,942
|
)
|
|
(1,380
|
)
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|
||||||
|
Dividends
|
(25,058
|
)
|
|
(14,737
|
)
|
|
(7,312
|
)
|
|||
|
Common stock repurchased
|
(101,073
|
)
|
|
(268,212
|
)
|
|
(204,109
|
)
|
|||
|
Warrants repurchased
|
(68,399
|
)
|
|
—
|
|
|
—
|
|
|||
|
Excess tax benefit on share-based compensation
|
79
|
|
|
22
|
|
|
14
|
|
|||
|
Proceeds from issuance of Senior Notes, net of discount
|
—
|
|
|
374,411
|
|
|
—
|
|
|||
|
Payment of note issued to Citigroup
|
—
|
|
|
(300,000
|
)
|
|
—
|
|
|||
|
Payments of deferred financing costs
|
—
|
|
|
(3,109
|
)
|
|
—
|
|
|||
|
Net cash provided by (used in) financing activities
|
(194,451
|
)
|
|
(211,625
|
)
|
|
(211,407
|
)
|
|||
|
Change in cash and cash equivalents
|
1,065
|
|
|
(17,797
|
)
|
|
27,843
|
|
|||
|
Cash and cash equivalents, beginning of period
|
10,296
|
|
|
28,093
|
|
|
250
|
|
|||
|
Cash and cash equivalents, end of period
|
$
|
11,361
|
|
|
$
|
10,296
|
|
|
$
|
28,093
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
||||||
|
Interest paid
|
$
|
17,070
|
|
|
$
|
15,858
|
|
|
$
|
16,500
|
|
|
|
|
|
|
|
|
||||||
|
Non-cash activities:
|
|
|
|
|
|
||||||
|
Share-based compensation
|
$
|
39,195
|
|
|
$
|
33,236
|
|
|
$
|
29,444
|
|
|
Net contributions from Citigroup
|
—
|
|
|
1,961
|
|
|
1,426
|
|
|||
|
*
|
Eliminated in consolidation.
|
|
(1)
|
Includes
$38,535
eliminated in consolidation for the year ended
December 31, 2012
.
|
|
|
Deferred policy acquisition costs
|
|
Future policy benefits
|
|
Unearned premiums
|
|
Other policy benefits and claims payable
|
|
Separate account liabilities
|
||||||||||
|
|
|
|
|
|
|||||||||||||||
|
|
(In thousands)
|
||||||||||||||||||
|
December 31, 2013:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Term Life Insurance
|
$
|
1,115,286
|
|
|
$
|
4,889,335
|
|
|
$
|
—
|
|
|
$
|
237,197
|
|
|
$
|
—
|
|
|
Investment and Savings Products
|
63,607
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,503,197
|
|
|||||
|
Corporate and Other Distributed Products
|
29,573
|
|
|
173,768
|
|
|
1,802
|
|
|
16,107
|
|
|
632
|
|
|||||
|
Total
|
$
|
1,208,466
|
|
|
$
|
5,063,103
|
|
|
$
|
1,802
|
|
|
$
|
253,304
|
|
|
$
|
2,503,829
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Term Life Insurance
|
$
|
967,454
|
|
|
$
|
4,681,437
|
|
|
$
|
—
|
|
|
$
|
235,763
|
|
|
$
|
—
|
|
|
Investment and Savings Products
|
68,812
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,617,299
|
|
|||||
|
Corporate and Other Distributed Products
|
30,156
|
|
|
169,051
|
|
|
6,056
|
|
|
18,770
|
|
|
816
|
|
|||||
|
Total
|
$
|
1,066,422
|
|
|
$
|
4,850,488
|
|
|
$
|
6,056
|
|
|
$
|
254,533
|
|
|
$
|
2,618,115
|
|
|
|
Premium revenues
|
|
Net investment income
|
|
Benefits and claims
|
|
Amortization of deferred policy acquisition costs
|
|
Other operating expenses
|
|
Premiums written
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||||||||
|
|
(In thousands)
|
||||||||||||||||||||||
|
Year ended December 31, 2013:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Term Life Insurance
|
$
|
597,162
|
|
|
$
|
68,796
|
|
|
$
|
262,357
|
|
|
$
|
115,891
|
|
|
$
|
119,526
|
|
|
$
|
—
|
|
|
Investment and Savings Products
|
—
|
|
|
—
|
|
|
—
|
|
|
11,195
|
|
|
340,794
|
|
|
—
|
|
||||||
|
Corporate and Other Distributed Products
|
60,749
|
|
|
19,956
|
|
|
39,118
|
|
|
2,097
|
|
|
125,272
|
|
|
35,897
|
|
||||||
|
Total
|
$
|
657,911
|
|
|
$
|
88,752
|
|
|
$
|
301,475
|
|
|
$
|
129,183
|
|
|
$
|
585,592
|
|
|
$
|
35,897
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Year ended December 31, 2012:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Term Life Insurance
|
$
|
543,658
|
|
|
$
|
66,119
|
|
|
$
|
239,346
|
|
|
$
|
104,272
|
|
|
$
|
110,590
|
|
|
$
|
—
|
|
|
Investment and Savings Products
|
—
|
|
|
—
|
|
|
—
|
|
|
10,956
|
|
|
281,893
|
|
|
—
|
|
||||||
|
Corporate and Other Distributed Products
|
60,564
|
|
|
34,685
|
|
|
39,401
|
|
|
3,370
|
|
|
133,999
|
|
|
39,102
|
|
||||||
|
Total
|
$
|
604,222
|
|
|
$
|
100,804
|
|
|
$
|
278,747
|
|
|
$
|
118,598
|
|
|
$
|
526,482
|
|
|
$
|
39,102
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Year ended December 31, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Term Life Insurance
|
$
|
460,641
|
|
|
$
|
60,667
|
|
|
$
|
197,159
|
|
|
$
|
89,474
|
|
|
$
|
105,912
|
|
|
$
|
—
|
|
|
Investment and Savings Products
|
—
|
|
|
—
|
|
|
—
|
|
|
12,482
|
|
|
267,145
|
|
|
—
|
|
||||||
|
Corporate and Other Distributed Products
|
65,751
|
|
|
47,934
|
|
|
45,537
|
|
|
2,078
|
|
|
139,397
|
|
|
41,891
|
|
||||||
|
Total
|
$
|
526,392
|
|
|
$
|
108,601
|
|
|
$
|
242,696
|
|
|
$
|
104,034
|
|
|
$
|
512,454
|
|
|
$
|
41,891
|
|
|
|
Year Ended December 31, 2013
|
|||||||||||||||||
|
|
Gross amount
|
|
Ceded to other companies
|
|
Assumed from other companies
|
|
Net amount
|
|
Percentage of amount assumed to net
|
|||||||||
|
|
|
|
|
|
||||||||||||||
|
|
(Dollars in thousands)
|
|||||||||||||||||
|
Life insurance in force
|
$
|
679,337,825
|
|
|
$
|
601,309,340
|
|
|
$
|
—
|
|
|
$
|
78,028,485
|
|
|
—
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
2,262,721
|
|
|
$
|
1,642,775
|
|
|
$
|
—
|
|
|
$
|
619,946
|
|
|
—
|
%
|
|
Accident and health insurance
|
39,348
|
|
|
1,383
|
|
|
—
|
|
|
37,965
|
|
|
—
|
%
|
||||
|
Total premiums
|
$
|
2,302,069
|
|
|
$
|
1,644,158
|
|
|
$
|
—
|
|
|
$
|
657,911
|
|
|
—
|
%
|
|
|
Year Ended December 31, 2012
|
|||||||||||||||||
|
|
Gross amount
|
|
Ceded to other companies
|
|
Assumed from other companies
|
|
Net amount
|
|
Percentage of amount assumed to net
|
|||||||||
|
|
|
|
|
|
||||||||||||||
|
|
(Dollars in thousands)
|
|||||||||||||||||
|
Life insurance in force
|
$
|
675,164,992
|
|
|
$
|
599,133,626
|
|
|
$
|
—
|
|
|
$
|
76,031,366
|
|
|
—
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
2,227,821
|
|
|
$
|
1,661,822
|
|
|
$
|
—
|
|
|
$
|
565,999
|
|
|
—
|
%
|
|
Accident and health insurance
|
40,154
|
|
|
1,931
|
|
|
—
|
|
|
38,223
|
|
|
—
|
%
|
||||
|
Total premiums
|
$
|
2,267,975
|
|
|
$
|
1,663,753
|
|
|
$
|
—
|
|
|
$
|
604,222
|
|
|
—
|
%
|
|
|
Year Ended December 31, 2011
|
|||||||||||||||||
|
|
Gross amount
|
|
Ceded to other companies
|
|
Assumed from other companies
|
|
Net amount
|
|
Percentage of amount assumed to net
|
|||||||||
|
|
|
|
|
|
||||||||||||||
|
|
(Dollars in thousands)
|
|||||||||||||||||
|
Life insurance in force
|
$
|
669,938,841
|
|
|
$
|
596,975,143
|
|
|
$
|
—
|
|
|
$
|
72,963,698
|
|
|
—
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
2,185,791
|
|
|
$
|
1,701,269
|
|
|
$
|
—
|
|
|
$
|
484,522
|
|
|
—
|
%
|
|
Accident and health insurance
|
43,676
|
|
|
1,806
|
|
|
—
|
|
|
41,870
|
|
|
—
|
%
|
||||
|
Total premiums
|
$
|
2,229,467
|
|
|
$
|
1,703,075
|
|
|
$
|
—
|
|
|
$
|
526,392
|
|
|
—
|
%
|
|
Primerica, Inc.
|
|
|
|
||
|
|
|
|
|
||
|
By:
|
|
/s/
Alison S. Rand
|
|
|
February 27, 2014
|
|
|
|
Alison S. Rand
|
|
|
|
|
|
|
Executive Vice President and
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
/s/
D. Richard Williams
|
|
Chairman of the Board and Co-Chief Executive Officer (Principal Executive Officer)
|
February 27, 2014
|
|
D. Richard Williams
|
|
|
|
|
|
|
Chairman of Primerica Distribution and Co-Chief Executive Officer (Principal Executive Officer)
|
|
|
/s/
John A. Addison, Jr.
|
|
February 27, 2014
|
|
|
John A. Addison, Jr.
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
|
/s/
Alison S. Rand
|
|
February 27, 2014
|
|
|
Alison S. Rand
|
|
|
|
|
|
|
|
|
|
/s/
Joel M. Babbit
|
|
Director
|
February 27, 2014
|
|
Joel M. Babbit
|
|
|
|
|
|
|
|
|
|
/s/
P. George Benson
|
|
Director
|
February 27, 2014
|
|
P. George Benson
|
|
|
|
|
|
|
|
|
|
/s/
Gary L. Crittenden
|
|
Director
|
February 27, 2014
|
|
Gary L. Crittenden
|
|
|
|
|
|
|
|
|
|
/s/
Cynthia N. Day
|
|
Director
|
February 27, 2014
|
|
Cynthia N. Day
|
|
|
|
|
|
|
|
|
|
/s/
Michael E. Martin
|
|
Director
|
February 27, 2014
|
|
Michael E. Martin
|
|
|
|
|
|
|
|
|
|
/s/
Mark Mason
|
|
Director
|
February 27, 2014
|
|
Mark Mason
|
|
|
|
|
|
|
|
|
|
/s/
Robert F. McCullough
|
|
Director
|
February 27, 2014
|
|
Robert F. McCullough
|
|
|
|
|
|
|
|
|
|
/s/
Barbara A. Yastine
|
|
Director
|
February 27, 2014
|
|
Barbara A. Yastine
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|